<?xml version="1.0" encoding="utf-8"?><Regulation lims:pit-date="2025-06-21" hasPreviousVersion="true" lims:lastAmendedDate="2025-06-21" lims:current-date="2025-07-24" lims:inforce-start-date="2018-04-04" lims:fid="700314" lims:id="700314" regulation-type="SOR" xml:lang="en" xmlns:lims="http://justice.gc.ca/lims"><Identification lims:inforce-start-date="2018-04-04" lims:fid="700315" lims:id="700315"><InstrumentNumber>SOR/2003-196</InstrumentNumber><RegistrationDate><Date><YYYY>2003</YYYY><MM>6</MM><DD>5</DD></Date></RegistrationDate><ConsolidationDate lims:inforce-start-date="2018-04-04"><Date><YYYY>2025</YYYY><MM>7</MM><DD>25</DD></Date></ConsolidationDate><EnablingAuthority lims:inforce-start-date="2018-04-04" lims:fid="700317" lims:id="700317"><XRefExternal reference-type="act" link="F-27">FOOD AND DRUGS ACT</XRefExternal></EnablingAuthority><LongTitle lims:inforce-start-date="2018-04-04" lims:fid="700318" lims:id="700318">Natural Health Products Regulations</LongTitle><RegulationMakerOrder><RegulationMaker>P.C.</RegulationMaker><OrderNumber>2003-847</OrderNumber><Date><YYYY>2003</YYYY><MM>06</MM><DD>05</DD></Date></RegulationMakerOrder></Identification><Order lims:inforce-start-date="2018-04-04" lims:fid="700319" lims:id="700319"><Provision lims:inforce-start-date="2018-04-04" lims:fid="700320" lims:id="700320" language-align="yes" format-ref="indent-0-0" list-item="no"><Text>Her Excellency the Governor General in Council, on the recommendation of the Minister of Health, pursuant to subsection 30(1)<FootnoteRef idref="footnote_1">a</FootnoteRef> of the <XRefExternal reference-type="act" link="F-27">Food and Drugs Act</XRefExternal>, hereby makes the annexed <XRefExternal reference-type="regulation" link="SOR-2003-196">Natural Health Products Regulations</XRefExternal>.</Text><Footnote id="footnote_1" placement="page" status="official"><Label>a</Label><Text>S.C. 1999, c. 33, s. 347</Text></Footnote></Provision></Order><Body lims:inforce-start-date="2018-04-04" lims:fid="700321" lims:id="700321"><Heading lims:inforce-start-date="2018-04-04" lims:fid="700322" lims:id="700322" level="1"><TitleText>Interpretation</TitleText></Heading><Section lims:inforce-start-date="2018-04-04" lims:lastAmendedDate="2022-06-21" lims:fid="700323" lims:id="700323"><Label>1</Label><Subsection lims:inforce-start-date="2018-04-04" lims:fid="700324" lims:id="700324"><Label>(1)</Label><Text>The following definitions apply in these Regulations.</Text><Definition lims:inforce-start-date="2018-04-04" lims:fid="700325" lims:id="700325" generate-in-text="no"><Text><DefinedTermEn>Act</DefinedTermEn> means the <XRefExternal reference-type="act" link="F-27">Food and Drugs Act</XRefExternal>. (<DefinedTermFr>Loi</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362628" lims:id="1362628"><Text><DefinedTermEn>added sulphites</DefinedTermEn> means one or more of the food additives that are set out item 21, column 1, of table 2 of the Common Names for Ingredients and Components Document and are present in a natural health product as a result of being added to the product. (<DefinedTermFr>sulfites ajoutés</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2018-04-04" lims:fid="700326" lims:id="700326" generate-in-text="no"><Text><DefinedTermEn>adverse reaction</DefinedTermEn> means a noxious and unintended response to a natural health product that occurs at any dose used or tested for the diagnosis, treatment or prevention of a disease or for modifying an organic function. (<DefinedTermFr>réaction indésirable</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2018-04-04" lims:fid="700327" lims:id="700327" generate-in-text="no"><Text><DefinedTermEn>brand name</DefinedTermEn> means a name in English or French, whether or not it includes the name of a manufacturer, corporation, partnership or individual</Text><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700328" lims:id="700328"><Label>(a)</Label><Text>that is used to distinguish the natural health product; and</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700329" lims:id="700329"><Label>(b)</Label><Text>under which a natural health product is sold or advertised. (<DefinedTermFr>marque nominative</DefinedTermFr>)</Text></Paragraph></Definition><Definition lims:inforce-start-date="2018-04-04" lims:fid="700330" lims:id="700330" generate-in-text="no"><Text><DefinedTermEn>case report</DefinedTermEn> means a detailed record of all relevant data associated with the use of a natural health product in a subject. (<DefinedTermFr>fiche d’observation</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362629" lims:id="1362629"><Text><DefinedTermEn>Common Names for Ingredients and Components Document</DefinedTermEn> means the document entitled <XRefExternal reference-type="other">Common Names for Ingredients and Components</XRefExternal>, prepared by the Canadian Food Inspection Agency and published on its website, as amended from time to time. (<DefinedTermFr>document sur les noms usuels d’ingrédients et de constituants</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2018-04-04" lims:fid="700331" lims:id="700331" generate-in-text="no"><Text><DefinedTermEn>Compendium</DefinedTermEn> means the <XRefExternal reference-type="other">Compendium of Monographs</XRefExternal> published by the Department of Health and as amended from time to time. (<DefinedTermFr>Compendium</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2018-04-04" lims:fid="700332" lims:id="700332" generate-in-text="no"><Text><DefinedTermEn>distributor</DefinedTermEn> means a person who sells a natural health product to another person for the purpose of further sale by that other person. (<DefinedTermFr>distributeur</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2018-04-04" lims:fid="700333" lims:id="700333" generate-in-text="no"><Text><DefinedTermEn>expiry date</DefinedTermEn> means the earlier of</Text><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700334" lims:id="700334"><Label>(a)</Label><Text>the date, expressed at minimum as a year and month, that is the end of the stability period determined under section 52; and</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700335" lims:id="700335"><Label>(b)</Label><Text>the date, expressed at minimum as a year and month, after which the manufacturer recommends that the natural health product should not be used. (<DefinedTermFr>date limite d’utilisation</DefinedTermFr>)</Text></Paragraph></Definition><Definition lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362630" lims:id="1362630"><Text><DefinedTermEn>food allergen</DefinedTermEn> means any protein from any of the following foods, or any modified protein, including any protein fraction, that is derived from any of the following foods:</Text><Paragraph lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362631" lims:id="1362631"><Label>(a)</Label><Text>almonds, Brazil nuts, cashews, hazelnuts, macadamia nuts, pecans, pine nuts, pistachios or walnuts;</Text></Paragraph><Paragraph lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362632" lims:id="1362632"><Label>(b)</Label><Text>peanuts;</Text></Paragraph><Paragraph lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362633" lims:id="1362633"><Label>(c)</Label><Text>sesame seeds;</Text></Paragraph><Paragraph lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362634" lims:id="1362634"><Label>(d)</Label><Text>wheat or triticale;</Text></Paragraph><Paragraph lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362635" lims:id="1362635"><Label>(e)</Label><Text>eggs;</Text></Paragraph><Paragraph lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362636" lims:id="1362636"><Label>(f)</Label><Text>milk;</Text></Paragraph><Paragraph lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362637" lims:id="1362637"><Label>(g)</Label><Text>soybeans;</Text></Paragraph><Paragraph lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362638" lims:id="1362638"><Label>(h)</Label><Text>crustaceans;</Text></Paragraph><Paragraph lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362639" lims:id="1362639"><Label>(i)</Label><Text>molluscs;</Text></Paragraph><Paragraph lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362640" lims:id="1362640"><Label>(j)</Label><Text>fish; or</Text></Paragraph><Paragraph lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362641" lims:id="1362641"><Label>(k)</Label><Text>mustard seeds. (<DefinedTermFr>allergène alimentaire</DefinedTermFr>)</Text></Paragraph></Definition><Definition lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362642" lims:id="1362642"><Text><DefinedTermEn>food allergen source, gluten source and added sulphites statement</DefinedTermEn> means a statement appearing on the label of a natural health product that indicates the source of a food allergen or gluten that is present in the product or the presence in the product of added sulphites in a total amount of 10 p.p.m. or more. (<DefinedTermFr>mention des sources d’allergènes alimentaires ou de gluten et des sulfites ajoutés</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362643" lims:id="1362643"><Text><DefinedTermEn>gluten</DefinedTermEn> means</Text><Paragraph lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362644" lims:id="1362644"><Label>(a)</Label><Text>any gluten protein from the grain of any of the following cereals or from the grain of a hybridized strain that is created from at least one of the following cereals:</Text><Subparagraph lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362645" lims:id="1362645"><Label>(i)</Label><Text>barley,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362646" lims:id="1362646"><Label>(ii)</Label><Text>oats,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362647" lims:id="1362647"><Label>(iii)</Label><Text>rye,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362648" lims:id="1362648"><Label>(iv)</Label><Text>triticale,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362649" lims:id="1362649"><Label>(v)</Label><Text>wheat; or</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362650" lims:id="1362650"><Label>(b)</Label><Text>any modified gluten protein, including any gluten protein fraction, that is derived from the grain of any of the cereals referred to in paragraph (a) or from the grain of a hybridized strain referred to in that paragraph. (<DefinedTermFr>gluten</DefinedTermFr>)</Text></Paragraph></Definition><Definition lims:inforce-start-date="2018-04-04" lims:fid="700336" lims:id="700336" generate-in-text="no"><Text><DefinedTermEn>immediate container</DefinedTermEn> means the container that is in direct contact with a natural health product. (<DefinedTermFr>contenant immédiat</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2018-04-04" lims:fid="700337" lims:id="700337" generate-in-text="no"><Text><DefinedTermEn>importer</DefinedTermEn> means a person who imports a natural health product into Canada for the purpose of sale. (<DefinedTermFr>importateur</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2018-04-04" lims:fid="700338" lims:id="700338" generate-in-text="no"><Text><DefinedTermEn>inner label</DefinedTermEn> means the label on or affixed to an immediate container of a natural health product. (<DefinedTermFr>étiquette intérieure</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2020-07-01" lims:enacted-date="2020-04-07" lims:fid="1254089" lims:id="1254089"><Text><DefinedTermEn>List A</DefinedTermEn> means the document entitled <XRefExternal reference-type="other">List of Certain Natural Health Products for Distribution as Samples</XRefExternal>, dated March 2020 and published by the Government of Canada on its website. (<DefinedTermFr>Liste A</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2018-04-04" lims:fid="700339" lims:id="700339" generate-in-text="no"><Text><DefinedTermEn>lot number</DefinedTermEn> means any combination of letters, figures, or both, by which a natural health product can be traced in manufacture and identified in distribution. (<DefinedTermFr>numéro de lot</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2018-04-04" lims:fid="700340" lims:id="700340" generate-in-text="no"><Text><DefinedTermEn>manufacturer</DefinedTermEn> means a person who fabricates or processes a natural health product for the purpose of sale, but does not include a pharmacist or other health care practitioner who, at the request of a patient, compounds a natural health product for the purpose of sale to that patient. (<DefinedTermFr>fabricant</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2018-04-04" lims:fid="700341" lims:id="700341" generate-in-text="no"><Text><DefinedTermEn>natural health product</DefinedTermEn> means a substance set out in Schedule 1 or a combination of substances in which all the medicinal ingredients are substances set out in Schedule 1, a homeopathic medicine or a traditional medicine, that is manufactured, sold or represented for use in</Text><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700342" lims:id="700342"><Label>(a)</Label><Text>the diagnosis, treatment, mitigation or prevention of a disease, disorder or abnormal physical state or its symptoms in humans;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700343" lims:id="700343"><Label>(b)</Label><Text>restoring or correcting organic functions in humans; or</Text></Paragraph><Paragraph lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="700344" lims:id="1362627"><Label>(c)</Label><Text>modifying organic functions in humans.</Text></Paragraph><ContinuedDefinition lims:inforce-start-date="2018-04-04" lims:fid="700345" lims:id="700345"><Text>However, a natural health product does not include a substance set out in Schedule 2, any combination of substances that includes a substance set out in Schedule 2 or a homeopathic medicine or a traditional medicine that is or includes a substance set out in Schedule 2. (<DefinedTermFr>produit de santé naturel</DefinedTermFr>)</Text></ContinuedDefinition></Definition><Definition lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="700346" lims:id="1362626"><Text><DefinedTermEn>outer label</DefinedTermEn> means the label on or affixed to the outside of a package, other than the immediate container, of a natural health product. (<DefinedTermFr>étiquette extérieure</DefinedTermFr>) </Text></Definition><Definition lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362651" lims:id="1362651"><Text><DefinedTermEn>point</DefinedTermEn> means the unit of measurement for type size that is known as a PostScript point and is equal to 0.3527777778 mm. (<DefinedTermFr>point</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2018-04-04" lims:fid="700347" lims:id="700347" generate-in-text="no"><Text><DefinedTermEn>principal display panel</DefinedTermEn> has the same meaning as in the <XRefExternal reference-type="regulation" link="C.R.C.,_c._417">Consumer Packaging and Labelling Regulations</XRefExternal>. (<DefinedTermFr>espace principal</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2018-04-04" lims:fid="700348" lims:id="700348" generate-in-text="no"><Text><DefinedTermEn>probiotic</DefinedTermEn> means a monoculture or mixed-culture of live micro-organisms that benefit the microbiota indigenous to humans. (<DefinedTermFr>probiotique</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2018-04-04" lims:fid="700349" lims:id="700349" generate-in-text="no"><Text><DefinedTermEn>proper name</DefinedTermEn> means, in respect of an ingredient of a natural health product, one of the following:</Text><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700350" lims:id="700350"><Label>(a)</Label><Text>if the ingredient is a vitamin, the name for that vitamin set out in item 3 of Schedule 1;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700351" lims:id="700351"><Label>(b)</Label><Text>if the ingredient is a plant or a plant material, an alga, a bacterium, a fungus, a non-human animal material or a probiotic, the Latin nomenclature of its genus and, if any, its specific epithet; and</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700352" lims:id="700352"><Label>(c)</Label><Text>if the ingredient is other than one described in paragraphs (a) or (b), the chemical name of the ingredient. (<DefinedTermFr>nom propre</DefinedTermFr>)</Text></Paragraph></Definition><Definition lims:inforce-start-date="2018-04-04" lims:fid="700353" lims:id="700353" generate-in-text="no"><Text><DefinedTermEn>recommended conditions of use</DefinedTermEn> means, in respect of a natural health product,</Text><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700354" lims:id="700354"><Label>(a)</Label><Text>its recommended use or purpose;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700355" lims:id="700355"><Label>(b)</Label><Text>its dosage form;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700356" lims:id="700356"><Label>(c)</Label><Text>its recommended route of administration;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700357" lims:id="700357"><Label>(d)</Label><Text>its recommended dose;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700358" lims:id="700358"><Label>(e)</Label><Text>its recommended duration of use, if any; and</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700359" lims:id="700359"><Label>(f)</Label><Text>its risk information, including any cautions, warnings, contra-indications or known adverse reactions associated with its use. (<DefinedTermFr>conditions d’utilisation recommandées</DefinedTermFr>)</Text></Paragraph></Definition><Definition lims:inforce-start-date="2018-04-04" lims:fid="700360" lims:id="700360" generate-in-text="no"><Text><DefinedTermEn>security package</DefinedTermEn> means a package having a security feature that provides reasonable assurance to consumers that the package has not been opened prior to purchase. (<DefinedTermFr>emballage de sécurité</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2018-04-04" lims:fid="700361" lims:id="700361" generate-in-text="no"><Text><DefinedTermEn>serious adverse reaction</DefinedTermEn> means a noxious and unintended response to a natural health product that occurs at any dose and that requires in-patient hospitalization or a prolongation of existing hospitalization, that causes congenital malformation, that results in persistent or significant disability or incapacity, that is life threatening or that results in death. (<DefinedTermFr>réaction indésirable grave</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2018-04-04" lims:fid="700362" lims:id="700362" generate-in-text="no"><Text><DefinedTermEn>serious unexpected adverse reaction</DefinedTermEn> means a serious adverse reaction that is not identified in nature, severity or frequency in the risk information set out on the label of the natural health product. (<DefinedTermFr>réaction indésirable grave et imprévue</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2018-04-04" lims:fid="700363" lims:id="700363" generate-in-text="no"><Text><DefinedTermEn>specifications</DefinedTermEn> means a description of a natural health product that contains the information described in subsection 44(2). (<DefinedTermFr>spécifications</DefinedTermFr>)</Text></Definition></Subsection><Subsection lims:inforce-start-date="2018-04-04" lims:fid="700364" lims:id="700364"><Label>(2)</Label><Text>Subject to subsection (3), the words and expressions used in the provisions of the <XRefExternal reference-type="regulation" link="C.R.C.,_c._870">Food and Drug Regulations</XRefExternal> that are incorporated by reference by these Regulations shall have the meanings assigned to them by these Regulations, but if no meanings are assigned, they shall have any meaning assigned to them by the <XRefExternal reference-type="regulation" link="C.R.C.,_c._870">Food and Drug Regulations</XRefExternal>.</Text></Subsection><Subsection lims:inforce-start-date="2018-04-04" lims:fid="700365" lims:id="700365"><Label>(3)</Label><Text>The word <DefinitionRef>manufacturer</DefinitionRef> in the provisions of the <XRefExternal reference-type="regulation" link="C.R.C.,_c._870">Food and Drug Regulations</XRefExternal> that are incorporated by reference by these Regulations shall have the meaning assigned to it by the <XRefExternal reference-type="regulation" link="C.R.C.,_c._870">Food and Drug Regulations</XRefExternal>.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2018-04-04" lims:fid="700367" lims:id="700367">SOR/2018-69, s. 41</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2020-07-01" lims:enacted-date="2020-04-07" lims:fid="1254088" lims:id="1254088" lims:enactId="1243925">SOR/2020-75, s. 1</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362652" lims:id="1362652" lims:enactId="1358407">SOR/2022-146, s. 1</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700368" lims:id="700368" level="1"><TitleText>Application</TitleText></Heading><Section lims:inforce-start-date="2018-04-04" lims:lastAmendedDate="2018-04-04" lims:fid="700369" lims:id="700369"><Label>2</Label><Subsection lims:inforce-start-date="2018-04-04" lims:fid="700370" lims:id="700370"><Label>(1)</Label><Text>These Regulations apply to</Text><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700371" lims:id="700371"><Label>(a)</Label><Text>the sale of natural health products;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700372" lims:id="700372"><Label>(b)</Label><Text>the manufacture, packaging, labelling and importation for sale of natural health products;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700373" lims:id="700373"><Label>(c)</Label><Text>the distribution of natural health products; and</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700374" lims:id="700374"><Label>(d)</Label><Text>the storage of natural health products for the purposes of any of the activities referred to in paragraphs (b) and (c).</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2018-04-04" lims:fid="700375" lims:id="700375"><Label>(2)</Label><Text>For the purposes of these Regulations, a substance or combination of substances or a traditional medicine is not considered to be a natural health product if its sale, under the <XRefExternal reference-type="regulation" link="C.R.C.,_c._870">Food and Drug Regulations</XRefExternal>, is required to be pursuant to a prescription when it is sold other than in accordance with section C.01.043 of those Regulations.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2018-04-04" lims:fid="700377" lims:id="700377">SOR/2018-69, s. 42(F)</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="700378" lims:id="700378"><Label>3</Label><Text>Except where otherwise indicated in these Regulations, the provisions of the <XRefExternal reference-type="regulation" link="C.R.C.,_c._870">Food and Drug Regulations</XRefExternal> do not apply to natural health products.</Text></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700379" lims:id="700379" level="1"><Label>PART 1</Label><TitleText>Product Licences</TitleText></Heading><Heading lims:inforce-start-date="2018-04-04" lims:fid="700380" lims:id="700380" level="2"><TitleText>Prohibition</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="700381" lims:id="700381"><Label>4</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700382" lims:id="700382"><Label>(1)</Label><Text>Subject to subsections (2) and (3), no person shall sell a natural health product unless a product licence is issued in respect of the natural health product.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700383" lims:id="700383"><Label>(2)</Label><Text>No product licence holder, manufacturer, importer or distributor of a natural health product for which a product licence is issued shall sell the natural health product during any period that the sale of that natural health product is directed to be stopped under section 17.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700384" lims:id="700384"><Label>(3)</Label><Text>No person shall sell a natural health product for which a product licence is issued</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700385" lims:id="700385"><Label>(a)</Label><Text>during the period of any suspension of the licence under section 18 or 19; or</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700386" lims:id="700386"><Label>(b)</Label><Text>after cancellation of the licence under paragraph 20(b).</Text></Paragraph></Subsection></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700387" lims:id="700387" level="2"><TitleText>Licence Application</TitleText></Heading><Section lims:inforce-start-date="2018-04-04" lims:lastAmendedDate="2021-03-31" lims:fid="700388" lims:id="700388"><Label>5</Label><Text>An application for a product licence shall be submitted to the Minister and shall contain the following information and documents:</Text><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700389" lims:id="700389"><Label>(a)</Label><Text>the name, address and telephone number, and if applicable, the facsimile number and electronic mail address of the applicant;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700390" lims:id="700390"><Label>(b)</Label><Text>if the address submitted under paragraph (a) is not a Canadian address, the name, address and telephone number, and if applicable, the facsimile number and electronic mail address of the applicant’s representative in Canada to whom notices may be sent;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700391" lims:id="700391"><Label>(c)</Label><Text>for each medicinal ingredient of the natural health product,</Text><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700392" lims:id="700392"><Label>(i)</Label><Text>its proper name and its common name,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700393" lims:id="700393"><Label>(ii)</Label><Text>its quantity per dosage unit,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700394" lims:id="700394"><Label>(iii)</Label><Text>its potency, if a representation relating to its potency is to be shown on any label of the natural health product,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700395" lims:id="700395"><Label>(iv)</Label><Text>a description of its source material, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700396" lims:id="700396"><Label>(v)</Label><Text>a statement indicating whether it is synthetically manufactured;</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700397" lims:id="700397"><Label>(d)</Label><Text>a qualitative list of the non-medicinal ingredients that are proposed for the natural health product and for each ingredient listed, a statement that indicates the purpose of the ingredient;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700398" lims:id="700398"><Label>(e)</Label><Text>each brand name under which the natural health product is proposed to be sold;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700399" lims:id="700399"><Label>(f)</Label><Text>the recommended conditions of use for the natural health product;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700400" lims:id="700400"><Label>(g)</Label><Text>information that demonstrates the safety and efficacy of the natural health product when it is used in accordance with the recommended conditions of use;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700401" lims:id="700401"><Label>(h)</Label><Text>the text of each label that is proposed to be used in conjunction with the natural health product;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700402" lims:id="700402"><Label>(i)</Label><Text>a copy of the specifications to which the natural health product will comply; and</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700403" lims:id="700403"><Label>(j)</Label><Text>one of the following attestations, namely,</Text><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700404" lims:id="700404"><Label>(i)</Label><Text>if the natural health product is imported, an attestation by the applicant that the natural health product will be manufactured, packaged, labelled, imported, distributed and stored in accordance with the requirements set out in Part 3 or in accordance with requirements that are equivalent to those set out in Part 3, or</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700405" lims:id="700405"><Label>(ii)</Label><Text>if the natural health product is not imported, an attestation by the applicant that the natural health product will be manufactured, packaged, labelled, distributed and stored in accordance with requirements set out in Part 3.</Text></Subparagraph></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2018-04-04" lims:fid="700407" lims:id="700407">SOR/2018-69, s. 43(E)</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2021-03-31" lims:enacted-date="2021-03-18" lims:fid="1290025" lims:id="1290025" lims:enactId="1288932">SOR/2021-46, s. 17(F)</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700408" lims:id="700408" level="2"><TitleText>Sixty-Day Disposition</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="700409" lims:id="700409"><Label>6</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700410" lims:id="700410"><Label>(1)</Label><Text>Subject to subsection (2), the Minister shall dispose of an application submitted under section 5 within 60 days after the day on which it is submitted if, in support of the application, the only information submitted by the applicant under paragraph 5(g) is that which is</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700411" lims:id="700411"><Label>(a)</Label><Text>in the case of an application respecting a natural health product that has only one medicinal ingredient, contained in a monograph for that medicinal ingredient in the Compendium; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700412" lims:id="700412"><Label>(b)</Label><Text>in the case of an application respecting a natural health product that has more than one medicinal ingredient, contained in a monograph for that combination of medicinal ingredients in the Compendium.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700413" lims:id="700413"><Label>(2)</Label><Text>If the Minister requests that additional information or samples be submitted under section 15, the 60-day period referred to in subsection (1) does not include the number of days beginning on the day on which the request is made and ending on the day on which the additional information or samples are received.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700414" lims:id="700414"><Label>(3)</Label><Text>For the purposes of this section, the Minister disposes of an application on the earlier of the day on which</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700415" lims:id="700415"><Label>(a)</Label><Text>the licence is issued in accordance with section 7; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700416" lims:id="700416"><Label>(b)</Label><Text>the applicant is sent a notice under subsection 9(1).</Text></Paragraph></Subsection></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700417" lims:id="700417" level="2"><TitleText>Issuance and Amendment</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="700418" lims:id="700418"><Label>7</Label><Text>The Minister shall issue or amend a product licence if</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700419" lims:id="700419"><Label>(a)</Label><Text>the applicant submits an application to the Minister that is in accordance with section 5 or subsection 11(2), as the case may be;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700420" lims:id="700420"><Label>(b)</Label><Text>the applicant submits to the Minister all additional information or samples requested under section 15;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700421" lims:id="700421"><Label>(c)</Label><Text>the applicant does not make a false or misleading statement in the application; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700422" lims:id="700422"><Label>(d)</Label><Text>the issuance or amendment of the licence, as the case may be, is not likely to result in injury to the health of a purchaser or consumer.</Text></Paragraph></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700423" lims:id="700423" level="2"><TitleText>Product Number</TitleText></Heading><Section lims:inforce-start-date="2018-04-04" lims:lastAmendedDate="2018-04-04" lims:fid="700424" lims:id="700424"><Label>8</Label><Subsection lims:inforce-start-date="2018-04-04" lims:fid="700425" lims:id="700425"><Label>(1)</Label><Text>The Minister shall assign a product number to each natural health product in respect of which a product licence is issued.</Text></Subsection><Subsection lims:inforce-start-date="2018-04-04" lims:fid="700426" lims:id="700426"><Label>(2)</Label><Text>In the case of a natural health product that is a drug for which a drug identification number is assigned in accordance with subsection C.01.014.2(1) of the <XRefExternal reference-type="regulation" link="C.R.C.,_c._870">Food and Drug Regulations</XRefExternal>, the product number assigned under subsection (1) shall be the drug identification number.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2018-04-04" lims:fid="700428" lims:id="700428">SOR/2018-69, s. 44(E)</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700429" lims:id="700429" level="2"><TitleText>Refusal to Issue or Amend</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2022-06-21" lims:fid="700430" lims:id="700430"><Label>9</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700431" lims:id="700431"><Label>(1)</Label><Text>If the Minister refuses to issue or amend a product licence, the Minister shall send the applicant a notice that sets out the reason for the refusal.</Text></Subsection><Subsection lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="700432" lims:id="1362653"><Label>(2)</Label><Text>The notice shall indicate that the applicant may, within 30 days after the date of the notice, request that the Minister reconsider the application.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700433" lims:id="700433"><Label>(3)</Label><Text>If the applicant makes a request in accordance with subsection (2), the Minister shall</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700434" lims:id="700434"><Label>(a)</Label><Text>give the applicant an opportunity to be heard in respect of the application; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700435" lims:id="700435"><Label>(b)</Label><Text>reconsider the application after giving the applicant that opportunity.</Text></Paragraph></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362655" lims:id="1362655" lims:enactId="1358414">SOR/2022-146, s. 2</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="700436" lims:id="700436"><Label>10</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700437" lims:id="700437"><Label>(1)</Label><Text>After reconsidering the application, the Minister shall issue or amend the product licence if the requirements of section 7 are met.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700438" lims:id="700438"><Label>(2)</Label><Text>If the Minister again refuses to issue or amend the product licence, the Minister shall send the applicant a final notice that sets out the reason for the refusal.</Text></Subsection></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700439" lims:id="700439" level="2"><TitleText>Amendment</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="700440" lims:id="700440"><Label>11</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700441" lims:id="700441"><Label>(1)</Label><Text>If the licensee makes any of the following changes in respect of the natural health product, the licensee shall not sell any lot or batch of the natural health product affected by the change unless the product licence is amended accordingly:</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700442" lims:id="700442"><Label>(a)</Label><Text>a change to its recommended dose;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700443" lims:id="700443"><Label>(b)</Label><Text>a change to its recommended duration of use;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700444" lims:id="700444"><Label>(c)</Label><Text>the deletion or modification of risk information shown on any of its labels, including the deletion or modification of a caution, warning, contra-indication or known adverse reaction associated with its use;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700445" lims:id="700445"><Label>(d)</Label><Text>a change of its recommended use or purpose;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700446" lims:id="700446"><Label>(e)</Label><Text>a change of the source material of any of its medicinal ingredients;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700447" lims:id="700447"><Label>(f)</Label><Text>changing any of its medicinal ingredients to or from being synthetically manufactured;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700448" lims:id="700448"><Label>(g)</Label><Text>a change to the potency of any of its medicinal ingredients;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700449" lims:id="700449"><Label>(h)</Label><Text>a change affecting its safety or efficacy that does not arise as a result of</Text><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="700450" lims:id="700450"><Label>(i)</Label><Text>a change to the quantity of a medicinal ingredient per dosage unit,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="700451" lims:id="700451"><Label>(ii)</Label><Text>the addition or substitution of a medicinal ingredient,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="700452" lims:id="700452"><Label>(iii)</Label><Text>a change to its dosage form, or</Text></Subparagraph><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="700453" lims:id="700453"><Label>(iv)</Label><Text>a change to its recommended route of administration; or</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700454" lims:id="700454"><Label>(i)</Label><Text>one or more of the following changes to its specifications, namely,</Text><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="700455" lims:id="700455"><Label>(i)</Label><Text>the removal of a test method set out in the specifications,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="700456" lims:id="700456"><Label>(ii)</Label><Text>the modification of a test method set out in the specifications in a manner that widens the purity tolerances of the natural health product or the quantity, identity or potency tolerances of any of its medicinal ingredients, or</Text></Subparagraph><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="700457" lims:id="700457"><Label>(iii)</Label><Text>the modification of a test method set out in the specifications in a manner that renders it less precise, accurate, specific or sensitive.</Text></Subparagraph></Paragraph></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700458" lims:id="700458"><Label>(2)</Label><Text>An application to amend a product licence shall be submitted to the Minister and shall contain the following information and documents:</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700459" lims:id="700459"><Label>(a)</Label><Text>the product number of the natural health product;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700460" lims:id="700460"><Label>(b)</Label><Text>a statement identifying each change described in subsection (1) that has been made;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700461" lims:id="700461"><Label>(c)</Label><Text>information demonstrating that the natural health product is safe and efficacious after the change;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700462" lims:id="700462"><Label>(d)</Label><Text>the text of each label to be used in conjunction with the natural health product after the change, if the change is any of those described in paragraphs (1)(a) to (h); and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700463" lims:id="700463"><Label>(e)</Label><Text>a copy of the revised specifications, if the change is any of those described in paragraph (1)(g) or (i).</Text></Paragraph></Subsection></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700464" lims:id="700464" level="2"><TitleText>Notification</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="700465" lims:id="700465"><Label>12</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700466" lims:id="700466"><Label>(1)</Label><Text>If the licensee makes any of the changes described in subsection (2) in respect of the natural health product, the licensee shall, within 60 days after the day on which the change is made,</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700467" lims:id="700467"><Label>(a)</Label><Text>notify the Minister of the change; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700468" lims:id="700468"><Label>(b)</Label><Text>provide the Minister with the text of each label used in conjunction with the natural health product since the change, if the change is any of those described in paragraphs (2)(d) to (f).</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700469" lims:id="700469"><Label>(2)</Label><Text>For the purposes of subsection (1), changes in respect of a natural health product are</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700470" lims:id="700470"><Label>(a)</Label><Text>a change to any of the information submitted under paragraph 5(a) or (b);</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700471" lims:id="700471"><Label>(b)</Label><Text>a change to any of the information provided under section 22;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700472" lims:id="700472"><Label>(c)</Label><Text>the addition or substitution of a non-medicinal ingredient, the addition or substitution of which does not affect its safety or efficacy;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700473" lims:id="700473"><Label>(d)</Label><Text>its sale under a brand name other than one submitted under paragraph 5(e);</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700474" lims:id="700474"><Label>(e)</Label><Text>a change of the common or proper name of any of its medicinal ingredients; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700475" lims:id="700475"><Label>(f)</Label><Text>the addition of risk information to any of its labels, including the addition of a caution, warning, contra-indication or known adverse reaction associated with its use.</Text></Paragraph></Subsection></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700476" lims:id="700476" level="2"><TitleText>Fundamental Change</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2022-06-21" lims:fid="700477" lims:id="700477"><Label>13</Label><Text lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362528" lims:id="1362656">For greater certainty, if the licensee makes any of the following fundamental changes in respect of the natural health product, the licensee shall not sell the natural health product affected by the change unless a product licence is issued in accordance with section 7 for the natural health product as changed:</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700478" lims:id="700478"><Label>(a)</Label><Text>a change to the quantity of a medicinal ingredient per dosage unit;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700479" lims:id="700479"><Label>(b)</Label><Text>the addition or substitution of a medicinal ingredient;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700480" lims:id="700480"><Label>(c)</Label><Text>a change to its dosage form; or</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700481" lims:id="700481"><Label>(d)</Label><Text>a change to its recommended route of administration.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362658" lims:id="1362658" lims:enactId="1358416">SOR/2022-146, s. 3(E)</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700482" lims:id="700482" level="2"><TitleText>Licence Contents</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="700483" lims:id="700483"><Label>14</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700484" lims:id="700484"><Label>(1)</Label><Text>A product licence shall set out the following information:</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700485" lims:id="700485"><Label>(a)</Label><Text>the name and address of the licensee;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700486" lims:id="700486"><Label>(b)</Label><Text>the product number of the natural health product;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700487" lims:id="700487"><Label>(c)</Label><Text>the dosage form that is authorized for the natural health product;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700488" lims:id="700488"><Label>(d)</Label><Text>the recommended route of administration that is authorized for the natural health product;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700489" lims:id="700489"><Label>(e)</Label><Text>the recommended dose that is authorized for the natural health product;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700490" lims:id="700490"><Label>(f)</Label><Text>the recommended duration of use, if any, that is authorized for the natural health product;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700491" lims:id="700491"><Label>(g)</Label><Text>in respect of each medicinal ingredient of the natural health product</Text><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="700492" lims:id="700492"><Label>(i)</Label><Text>its authorized quantity per dosage unit,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="700493" lims:id="700493"><Label>(ii)</Label><Text>its authorized potency, if any, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="700494" lims:id="700494"><Label>(iii)</Label><Text>its authorized source material;</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700495" lims:id="700495"><Label>(h)</Label><Text>the recommended use or purpose that is authorized for the natural health product; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700496" lims:id="700496"><Label>(i)</Label><Text>the date on which the licence was issued.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700497" lims:id="700497"><Label>(2)</Label><Text>Within 60 days after the day on which the product licence is issued, the licensee shall notify the Minister of any information set out on the licence that the licensee knows to be incorrect.</Text></Subsection></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700498" lims:id="700498" level="2"><TitleText>Additional Information or Samples</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="700499" lims:id="700499"><Label>15</Label><Text>If the information and documents submitted in respect of a product licence application under section 5 or an application for amendment under subsection 11(2) are insufficient to enable the Minister to determine whether the product licence should be issued or amended, as the case may be, the Minister may request that the applicant provide such additional information or samples of the natural health product as are necessary to make the determination.</Text></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700500" lims:id="700500" level="2"><TitleText>Safety Information</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="700501" lims:id="700501"><Label>16</Label><Text>If the Minister has reasonable grounds to believe that a natural health product may no longer be safe when used under the recommended conditions of use, the Minister may request that the licensee provide the Minister, within 15 days after the day on which the request is received, with information and documents demonstrating that the natural health product is safe when used under the recommended conditions of use.</Text></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700502" lims:id="700502" level="2"><TitleText>Direction to Stop Sale</TitleText></Heading><Section lims:inforce-start-date="2018-04-04" lims:lastAmendedDate="2021-03-31" lims:fid="700503" lims:id="700503"><Label>17</Label><Subsection lims:inforce-start-date="2018-04-04" lims:fid="700504" lims:id="700504"><Label>(1)</Label><Text>The Minister may direct the licensee, manufacturer, importer and distributor to stop their sale of a natural health product if</Text><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700505" lims:id="700505"><Label>(a)</Label><Text>the licensee does not, within the required period, provide the Minister with the information and documents requested under section 16;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700506" lims:id="700506"><Label>(b)</Label><Text>the information and documents provided by the licensee in accordance with section 16 do not demonstrate that the natural health product is safe when used under the recommended conditions of use;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700507" lims:id="700507"><Label>(c)</Label><Text>in the case of a natural health product that is imported, the Minister has reasonable grounds to believe that the natural health product is not manufactured, packaged, labelled, imported, distributed or stored in accordance with the requirements set out in Part 3 or in accordance with requirements that are equivalent to those set out in Part 3;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700508" lims:id="700508"><Label>(d)</Label><Text>in the case of a natural health product that is not imported, the Minister has reasonable grounds to believe that the natural health product is not manufactured, packaged, labelled, distributed or stored in accordance with the requirements set out in Part 3; or</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700509" lims:id="700509"><Label>(e)</Label><Text>the Minister has reasonable grounds to believe that the natural health product is not packaged or labelled in accordance with the requirements set out in Part 5.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2018-04-04" lims:fid="700510" lims:id="700510"><Label>(2)</Label><Text>The Minister shall lift a direction to stop the sale of a natural health product if the licensee provides the Minister with information and documents demonstrating that</Text><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700511" lims:id="700511"><Label>(a)</Label><Text>in the case of a direction to stop sale arising under either paragraph (1)(a) or (b), the natural health product is safe when used under the recommended conditions of use;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700512" lims:id="700512"><Label>(b)</Label><Text>in the case of a direction to stop sale arising under paragraph (1)(c), the natural health product is manufactured, packaged, labelled, imported, distributed and stored in accordance with the requirements set out in Part 3 or in accordance with requirements that are equivalent to those set out in Part 3;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700513" lims:id="700513"><Label>(c)</Label><Text>in the case of a direction to stop sale arising under paragraph (1)(d), the natural health product is manufactured, packaged, labelled, distributed and stored in accordance with the requirements set out in Part 3;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700514" lims:id="700514"><Label>(d)</Label><Text>in the case of a direction to stop sale arising under paragraph (1)(e), the natural health product is packaged and labelled in accordance with the requirements of Part 5; or</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700515" lims:id="700515"><Label>(e)</Label><Text>the situation giving rise to the direction to stop the sale of the natural health product did not exist.</Text></Paragraph></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2018-04-04" lims:fid="700517" lims:id="700517">SOR/2018-69, s. 45(F)</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2021-03-31" lims:enacted-date="2021-03-18" lims:fid="1290026" lims:id="1290026" lims:enactId="1288932">SOR/2021-46, s. 17(F)</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700518" lims:id="700518" level="2"><TitleText>Suspension and Cancellation</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2022-06-21" lims:fid="700519" lims:id="700519"><Label>18</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700520" lims:id="700520"><Label>(1)</Label><Text>Subject to subsection (2), the Minister may suspend a product licence if the Minister has reasonable grounds to believe that</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700521" lims:id="700521"><Label>(a)</Label><Text>the licensee has contravened these Regulations or any provision of the Act relating to the natural health product; or</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700522" lims:id="700522"><Label>(b)</Label><Text>the licensee has made a false or misleading statement in the application submitted under section 5 or the application for amendment under subsection 11(2).</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700523" lims:id="700523"><Label>(2)</Label><Text>Subject to section 19, the Minister shall not suspend a product licence unless</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700524" lims:id="700524"><Label>(a)</Label><Text>the Minister has sent the licensee a notice that sets out the reason for the intended suspension; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700525" lims:id="700525"><Label>(b)</Label><Text lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362529" lims:id="1362659">the licensee has not, within 90 days after the date of the notice referred to in paragraph (a), provided the Minister with information or documents demonstrating that the licence should not be suspended on the grounds that</Text><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="700526" lims:id="700526"><Label>(i)</Label><Text>the situation giving rise to the intended suspension did not exist, or</Text></Subparagraph><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="700527" lims:id="700527"><Label>(ii)</Label><Text>the situation giving rise to the intended suspension has been corrected.</Text></Subparagraph></Paragraph></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362661" lims:id="1362661" lims:enactId="1358418">SOR/2022-146, s. 4</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="700528" lims:id="700528"><Label>19</Label><Text>The Minister shall suspend a product licence before giving the licensee an opportunity to be heard if, as a result of any circumstance, the Minister has reasonable grounds to believe that it is necessary to do so to prevent injury to the health of a purchaser or consumer.</Text></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="700529" lims:id="700529"><Label>20</Label><Text>If the Minister suspends a product licence under section 18 or 19, the Minister shall send the licensee a notice that sets out the reason for the suspension and the day on which the suspension is effective, and the Minister shall</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700530" lims:id="700530"><Label>(a)</Label><Text>reinstate the licence if, within 90 days after the day on which the suspension is effective, the licensee provides the Minister with information or documents demonstrating that the situation giving rise to the suspension did not exist or that it has been corrected; or</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700531" lims:id="700531"><Label>(b)</Label><Text>cancel the licence if, within 90 days after the day on which the suspension is effective, the licensee has not provided the Minister with the information or documents referred to in paragraph (a).</Text></Paragraph></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="700532" lims:id="700532"><Label>21</Label><Text>If the Minister cancels a licence under paragraph 20(b), the Minister shall send the licensee a notice that sets out the reason for the cancellation and the day on which the cancellation is effective.</Text></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700533" lims:id="700533" level="2"><TitleText>Site Information</TitleText></Heading><Section lims:inforce-start-date="2018-04-04" lims:lastAmendedDate="2021-03-31" lims:fid="700534" lims:id="700534"><Label>22</Label><Subsection lims:inforce-start-date="2018-04-04" lims:fid="700535" lims:id="700535"><Label>(1)</Label><Text>Subject to subsection (2), the licensee shall provide the Minister with the following information prior to commencing the sale of the natural health product:</Text><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700536" lims:id="700536"><Label>(a)</Label><Text>in respect of each manufacturer, packager, labeller and importer of the natural health product</Text><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700537" lims:id="700537"><Label>(i)</Label><Text>the person’s name, address and telephone number, and if applicable, the person’s facsimile number and electronic mail address, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700538" lims:id="700538"><Label>(ii)</Label><Text>if the person conducts the activity in Canada, the number assigned to the site licence issued in respect of that activity;</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700539" lims:id="700539"><Label>(b)</Label><Text>the name, address and telephone number, and if applicable, the facsimile number and electronic mail address of each distributor of the natural health product;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700540" lims:id="700540"><Label>(c)</Label><Text>the address of each building in which the natural health product is manufactured, packaged or labelled;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700541" lims:id="700541"><Label>(d)</Label><Text>the address of each building in which the natural health product is stored for the purposes of importation or distribution; and</Text></Paragraph><Paragraph lims:inforce-start-date="2021-03-31" lims:enacted-date="2021-03-18" lims:fid="700542" lims:id="1290059"><Label>(e)</Label><Text>if the natural health product is imported, evidence establishing that the natural health product will be manufactured, packaged, labelled, imported, distributed and stored in accordance with the requirements set out in Part 3 or in accordance with requirements that are equivalent to those set out in Part 3.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2018-04-04" lims:fid="700543" lims:id="700543"><Label>(2)</Label><Text>If the natural health product is one in respect of which a drug identification number is assigned in accordance with subsection C.01.014.2(1) of the <XRefExternal reference-type="regulation" link="C.R.C.,_c._870">Food and Drug Regulations</XRefExternal> and at the time the product licence is issued in respect of the natural health product it is already being sold, the licensee shall provide the information referred to in subsection (1) within 30 days after the day on which the product licence is issued.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2018-04-04" lims:fid="700545" lims:id="700545">SOR/2018-69, s. 46(F)</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2021-03-31" lims:enacted-date="2021-03-18" lims:fid="1290027" lims:id="1290027" lims:enactId="1288932">SOR/2021-46, s. 17(F)</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2021-03-31" lims:enacted-date="2021-03-18" lims:fid="1290058" lims:id="1290058" lims:enactId="1288959">SOR/2021-46, s. 19(E)</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700546" lims:id="700546" level="2"><TitleText>Records</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="700547" lims:id="700547"><Label>23</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700548" lims:id="700548"><Label>(1)</Label><Text>Every licensee who sells a natural health product shall maintain the following records:</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700549" lims:id="700549"><Label>(a)</Label><Text>a list of all ingredients contained in each lot or batch of the natural health product that has been made available for sale; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700550" lims:id="700550"><Label>(b)</Label><Text>records containing sufficient information to enable the recall of every lot or batch of the natural health product that has been made available for sale.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700551" lims:id="700551"><Label>(2)</Label><Text>The records shall be maintained by the licensee for a period of one year following the expiry date of the natural health product to which that record relates.</Text></Subsection></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700552" lims:id="700552" level="2"><TitleText>Reaction Reporting</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="700553" lims:id="700553"><Label>24</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700554" lims:id="700554"><Label>(1)</Label><Text>A licensee shall provide the Minister with</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700555" lims:id="700555"><Label>(a)</Label><Text>a case report for each serious adverse reaction to the natural health product that occurs inside Canada, within 15 days after the day on which the licensee becomes aware of the reaction; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700556" lims:id="700556"><Label>(b)</Label><Text>a case report for each serious unexpected adverse reaction to the natural health product that occurs inside or outside Canada, within 15 days after the day on which the licensee becomes aware of the reaction.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700557" lims:id="700557"><Label>(2)</Label><Text>A licensee who sells a natural health product shall annually prepare and maintain a summary report that contains a concise and critical analysis of</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700558" lims:id="700558"><Label>(a)</Label><Text>all adverse reactions to the natural health product that have occurred inside Canada; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700559" lims:id="700559"><Label>(b)</Label><Text>all reactions for which a case report is required to be provided under subsection (1), that have occurred</Text><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="700560" lims:id="700560"><Label>(i)</Label><Text>during the previous 12 months, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="700561" lims:id="700561"><Label>(ii)</Label><Text>at a dose used or tested for the diagnosis, treatment or prevention of a disease or for modifying organic functions in humans.</Text></Subparagraph></Paragraph></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700562" lims:id="700562"><Label>(3)</Label><Text>If after reviewing a case report provided under subsection (1) or after reviewing any other safety data relating to the natural health product, the Minister has reasonable grounds to believe that the natural health product may no longer be safe when used under the recommended conditions of use, the Minister may request that, within 30 days after the day on which the request is received, the licensee</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700563" lims:id="700563"><Label>(a)</Label><Text>provide to the Minister a copy of any summary report prepared under subsection (2); or</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700564" lims:id="700564"><Label>(b)</Label><Text>prepare and provide to the Minister an interim summary report containing a concise and critical analysis of</Text><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="700565" lims:id="700565"><Label>(i)</Label><Text>all adverse reactions to the natural health product that have occurred inside Canada, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="700566" lims:id="700566"><Label>(ii)</Label><Text>all reactions for which a case report is required to be provided under subsection (1), that have occurred</Text><Clause lims:inforce-start-date="2006-03-22" lims:fid="700567" lims:id="700567"><Label>(A)</Label><Text>since the date of the most recent summary report prepared under subsection (2), and</Text></Clause><Clause lims:inforce-start-date="2006-03-22" lims:fid="700568" lims:id="700568"><Label>(B)</Label><Text>at a dose used or tested for the diagnosis, treatment or prevention of a disease or for modifying organic functions in humans.</Text></Clause></Subparagraph></Paragraph></Subsection></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700569" lims:id="700569" level="2"><TitleText>Recall Reporting</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="700570" lims:id="700570"><Label>25</Label><Text>Every licensee who commences a recall of a natural health product shall provide the Minister with the information referred to in section 62 within three days after the day on which the recall is commenced.</Text></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700571" lims:id="700571" level="1"><Label>PART 2</Label><TitleText>Site Licences</TitleText></Heading><Heading lims:inforce-start-date="2018-04-04" lims:fid="700572" lims:id="700572" level="2"><TitleText>Application</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="700573" lims:id="700573"><Label>26</Label><Text>This Part does not apply to any activity that is conducted in respect of a natural health product solely for the purposes of a clinical trial as defined in section 63.</Text></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700574" lims:id="700574" level="2"><TitleText>Prohibition</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2022-06-21" lims:fid="700575" lims:id="700575"><Label>27</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700576" lims:id="700576"><Label>(1)</Label><Text>Subject to subsection (2), no person shall manufacture, package, label or import a natural health product for sale unless</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700577" lims:id="700577"><Label>(a)</Label><Text>the person holds a site licence issued in respect of the activity; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700578" lims:id="700578"><Label>(b)</Label><Text>the person conducts the activity in accordance with the requirements set out in Part 3.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="700579" lims:id="1362662"><Label>(2)</Label><Text>No person who holds a site licence shall manufacture, package, label or import a natural health product for sale during the period of any suspension of the licence under section 39 or 40.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362664" lims:id="1362664" lims:enactId="1358420">SOR/2022-146, s. 5</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700582" lims:id="700582" level="2"><TitleText>Licence Application</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2021-03-31" lims:fid="700583" lims:id="700583"><Label>28</Label><Text>An application for a site licence shall be submitted to the Minister and shall contain the following information and documents:</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700584" lims:id="700584"><Label>(a)</Label><Text>the name, address and telephone number, and if applicable, the facsimile number and electronic mail address of the applicant;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700585" lims:id="700585"><Label>(b)</Label><Text>a statement specifying which one or more of the activities of manufacturing, packaging, labelling or importing the applicant is proposing to conduct;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700586" lims:id="700586"><Label>(c)</Label><Text>if the applicant is proposing to manufacture, package or label a natural health product, the address of each building in which each activity is proposed to be conducted;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700587" lims:id="700587"><Label>(d)</Label><Text>if the applicant is proposing to import a natural health product, the address of each building in which that natural health product is proposed to be stored;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700588" lims:id="700588"><Label>(e)</Label><Text>for each activity specified under paragraph (b), a statement indicating whether or not the applicant is proposing to conduct the activity in respect of a natural health product in sterile dosage form; and</Text></Paragraph><Paragraph lims:inforce-start-date="2021-03-31" lims:enacted-date="2021-03-18" lims:fid="700589" lims:id="1290063"><Label>(f)</Label><Text>in respect of the buildings, equipment, practices and procedures used to conduct each activity specified under paragraph (b), a report from a quality assurance person establishing that they comply with the requirements set out in Part 3.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2021-03-31" lims:enacted-date="2021-03-18" lims:fid="1290029" lims:id="1290029" lims:enactId="1288932">SOR/2021-46, s. 17(F)</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2021-03-31" lims:enacted-date="2021-03-18" lims:fid="1290062" lims:id="1290062" lims:enactId="1288959">SOR/2021-46, s. 19(E)</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700590" lims:id="700590" level="2"><TitleText>Issuance and Amendment</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="700591" lims:id="700591"><Label>29</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700592" lims:id="700592"><Label>(1)</Label><Text>The Minister shall issue or amend a site licence if</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700593" lims:id="700593"><Label>(a)</Label><Text>the applicant submits an application to the Minister that is in accordance with section 28 or subsection 32(2), as the case may be;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700594" lims:id="700594"><Label>(b)</Label><Text>the applicant provides the Minister with all additional information requested under section 37; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700595" lims:id="700595"><Label>(c)</Label><Text>the applicant does not make a false or misleading statement in the application.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700596" lims:id="700596"><Label>(2)</Label><Text>If the Minister issues a site licence, the Minister shall assign that licence a site licence number.</Text></Subsection></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700597" lims:id="700597" level="2"><TitleText>Refusal to Issue or Amend</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2022-06-21" lims:fid="700598" lims:id="700598"><Label>30</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700599" lims:id="700599"><Label>(1)</Label><Text>If the Minister refuses to issue or amend a site licence, the Minister shall send the applicant a notice that sets out the reason for the refusal.</Text></Subsection><Subsection lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="700600" lims:id="1362665"><Label>(2)</Label><Text>The notice shall indicate that the applicant may, within 30 days after the date of the notice, request that the Minister reconsider the application.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700601" lims:id="700601"><Label>(3)</Label><Text>If the applicant makes a request in accordance with subsection (2), the Minister shall</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700602" lims:id="700602"><Label>(a)</Label><Text>give the applicant an opportunity to be heard in respect of the application; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700603" lims:id="700603"><Label>(b)</Label><Text>reconsider the application after giving the applicant that opportunity.</Text></Paragraph></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362667" lims:id="1362667" lims:enactId="1358422">SOR/2022-146, s. 6</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="700604" lims:id="700604"><Label>31</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700605" lims:id="700605"><Label>(1)</Label><Text>After reconsidering the application, the Minister shall issue or amend the site licence if the requirements of subsection 29(1) are met.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700606" lims:id="700606"><Label>(2)</Label><Text>If the Minister again refuses to issue or amend the site licence, the Minister shall send the applicant a final notice that sets out the reason for the refusal.</Text></Subsection></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700607" lims:id="700607" level="2"><TitleText>Amendment</TitleText></Heading><Section lims:inforce-start-date="2018-04-04" lims:lastAmendedDate="2021-03-31" lims:fid="700608" lims:id="700608"><Label>32</Label><Subsection lims:inforce-start-date="2018-04-04" lims:fid="700609" lims:id="700609"><Label>(1)</Label><Text>A licensee shall not conduct any of the following activities unless the site licence is amended accordingly:</Text><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700610" lims:id="700610"><Label>(a)</Label><Text>conduct any activity for a which a site licence is required that the licensee is not already authorized to conduct;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700611" lims:id="700611"><Label>(b)</Label><Text>if the licensee is authorized to manufacture, package or label a natural health product, conduct that activity in a building in which they are not authorized to do so;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700612" lims:id="700612"><Label>(c)</Label><Text>if the licensee is authorized to import a natural health product, store a natural health product in a building in which they are not authorized to do so; or</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700613" lims:id="700613"><Label>(d)</Label><Text>if the licensee is authorized to conduct an activity, but not already authorized to conduct it in respect of a natural health product in sterile dosage form, conduct the activity in respect of a natural health product in that form.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2018-04-04" lims:fid="700614" lims:id="700614"><Label>(2)</Label><Text>An application to amend a site licence shall be submitted to the Minister and shall contain the following information and documents:</Text><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700615" lims:id="700615"><Label>(a)</Label><Text>the licence number;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700616" lims:id="700616"><Label>(b)</Label><Text>a statement that specifies each activity referred to in subsection (1) that the licensee is proposing to conduct; and</Text></Paragraph><Paragraph lims:inforce-start-date="2021-03-31" lims:enacted-date="2021-03-18" lims:fid="700617" lims:id="1290065"><Label>(c)</Label><Text>a report from a quality assurance person establishing that the buildings, equipment, practices and procedures used in respect of each activity conducted by the licensee will remain in compliance with the requirements set out in Part 3.</Text></Paragraph></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2018-04-04" lims:fid="700619" lims:id="700619">SOR/2018-69, s. 47(E)</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2021-03-31" lims:enacted-date="2021-03-18" lims:fid="1290050" lims:id="1290050" lims:enactId="1288951">SOR/2021-46, s. 18(F)</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2021-03-31" lims:enacted-date="2021-03-18" lims:fid="1290064" lims:id="1290064" lims:enactId="1288959">SOR/2021-46, s. 19(E)</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700620" lims:id="700620" level="2"><TitleText>Notification</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="700621" lims:id="700621"><Label>33</Label><Text>If the licensee makes any of the following changes, the licensee shall notify the Minister of the change within 60 days after the day on which the change is made:</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700622" lims:id="700622"><Label>(a)</Label><Text>a change to the information submitted under paragraph 28(a); and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700623" lims:id="700623"><Label>(b)</Label><Text>a change that substantially alters any building, equipment, practice or procedure in respect of which a report from a quality assurance person was submitted under paragraph 28(f).</Text></Paragraph></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700624" lims:id="700624" level="2"><TitleText>Licence Contents</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2021-03-31" lims:fid="700625" lims:id="700625"><Label>34</Label><Text>A site licence shall set out the following information:</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700626" lims:id="700626"><Label>(a)</Label><Text>the name and address of the licensee;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700627" lims:id="700627"><Label>(b)</Label><Text>the site licence number;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700628" lims:id="700628"><Label>(c)</Label><Text>each activity that the licensee is authorized to conduct and a statement indicating whether the activity is authorized to be conducted in respect of a natural health product in sterile dosage form;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700629" lims:id="700629"><Label>(d)</Label><Text>if the licensee is authorized to manufacture, package or label a natural health product, the address of each building in which the licensee is authorized to conduct that activity; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700630" lims:id="700630"><Label>(e)</Label><Text>if the licensee is authorized to import a natural health product, the address of each building in which the licensee is authorized to store that natural health product.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2021-03-31" lims:enacted-date="2021-03-18" lims:fid="1290015" lims:id="1290015" lims:enactId="1288925">SOR/2021-46, s. 13(F)</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700631" lims:id="700631" level="2"><TitleText>Expiry</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="700632" lims:id="700632"><Label>35</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700633" lims:id="700633"><Label>(1)</Label><Text>A site licence expires on the first anniversary of the day on which it was issued unless it is renewed in accordance with section 36.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700634" lims:id="700634"><Label>(2)</Label><Text>A site licence that is renewed in accordance with section 36 expires on the day on which the renewal period ends unless the licence is further renewed in accordance with section 36.</Text></Subsection></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700635" lims:id="700635" level="2"><TitleText>Renewal</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="700636" lims:id="700636"><Label>36</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700637" lims:id="700637"><Label>(1)</Label><Text>The Minister shall renew a site licence if</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700638" lims:id="700638"><Label>(a)</Label><Text>the licensee submits a request to renew the licence to the Minister no later than 30 days before the day on which the licence expires;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700639" lims:id="700639"><Label>(b)</Label><Text>the licensee provides the Minister with all additional information requested under section 37; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700640" lims:id="700640"><Label>(c)</Label><Text>the renewal of the licence is not likely to result in injury to the health of a purchaser or consumer.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700641" lims:id="700641"><Label>(2)</Label><Text>If the Minister renews a site licence, the Minister shall renew it for a period of</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700642" lims:id="700642"><Label>(a)</Label><Text>one year, if on the next anniversary of the day on which the licence was issued, the licensee will have held the licence for a period of less than three years;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700643" lims:id="700643"><Label>(b)</Label><Text>two years, if on the next anniversary of the day on which the licence was issued, the licensee will have held the licence for a period of at least three years but less than nine years; or</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700644" lims:id="700644"><Label>(c)</Label><Text>three years, if on the next anniversary of the day on which the licence was issued, the licensee will have held the licence for a period of nine years or more.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700645" lims:id="700645"><Label>(3)</Label><Text>A site licence renewal becomes effective on the day after the anniversary of the day on which the licence was issued.</Text></Subsection></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700646" lims:id="700646" level="2"><TitleText>Additional Information</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="700647" lims:id="700647"><Label>37</Label><Text>If the information and documents submitted in respect of an application under section 28, an application for amendment under subsection 32(2) or a request for renewal under section 36 are insufficient to enable the Minister to determine whether the licence should be issued, amended or renewed, as the case may be, the Minister may request that the applicant provide the Minister with such additional information as is necessary to make the determination.</Text></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700648" lims:id="700648" level="2"><TitleText>Relinquishment of Authorization</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="700649" lims:id="700649"><Label>38</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700650" lims:id="700650"><Label>(1)</Label><Text>A licensee may, by amendment of the site licence, relinquish any part of the authorization given to the licensee under this Part.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700651" lims:id="700651"><Label>(2)</Label><Text>An application to amend the site licence for the purposes of subsection (1) shall be submitted to the Minister and shall contain the following information and documents:</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700652" lims:id="700652"><Label>(a)</Label><Text>a document, signed and dated by the licensee, that sets out the site licence number and that specifies each activity or, by address, each building, in respect of which the authorization is requested to be relinquished; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700653" lims:id="700653"><Label>(b)</Label><Text>an attestation, signed and dated by a quality assurance person, stating that after the relinquishment, the buildings, equipment, practices and procedures used in respect of each activity conducted by the licensee will remain in compliance with the requirements set out in Part 3.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700654" lims:id="700654"><Label>(3)</Label><Text>The Minister shall amend the site licence as requested by the licensee in paragraph (2)(a) if the licensee provides the Minister with an application that is in accordance with subsection (2).</Text></Subsection></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700655" lims:id="700655" level="2"><TitleText>Suspension and Cancellation</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2022-06-21" lims:fid="700656" lims:id="700656"><Label>39</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700657" lims:id="700657"><Label>(1)</Label><Text>Subject to subsection (2), the Minister may suspend a site licence if the Minister has reasonable grounds to believe that</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700658" lims:id="700658"><Label>(a)</Label><Text>the licensee has contravened any provision of the Act or these Regulations; or</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700659" lims:id="700659"><Label>(b)</Label><Text>the licensee has made a false or misleading statement in the application submitted under section 28 or the application for amendment under subsection 32(2).</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700660" lims:id="700660"><Label>(2)</Label><Text>Subject to section 40, the Minister shall not suspend a site licence unless</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700661" lims:id="700661"><Label>(a)</Label><Text>the Minister has sent the licensee a notice that sets out the reason for the intended suspension; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700662" lims:id="700662"><Label>(b)</Label><Text lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362530" lims:id="1362668">the licensee has not, within 90 days after the date of the notice referred to in paragraph (a), provided the Minister with information or documents demonstrating that the licence should not be suspended on the grounds that</Text><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="700663" lims:id="700663"><Label>(i)</Label><Text>the situation giving rise to the intended suspension did not exist, or</Text></Subparagraph><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="700664" lims:id="700664"><Label>(ii)</Label><Text>the situation giving rise to the intended suspension has been corrected.</Text></Subparagraph></Paragraph></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362670" lims:id="1362670" lims:enactId="1358424">SOR/2022-146, s. 7</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="700665" lims:id="700665"><Label>40</Label><Text>The Minister shall suspend a site licence before giving the licensee an opportunity to be heard if, as a result of any circumstance, the Minister has reasonable grounds to believe that it is necessary to do so to prevent injury to the health of a purchaser or consumer.</Text></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="700666" lims:id="700666"><Label>41</Label><Text>If the Minister suspends a site licence under section 39 or 40, the Minister shall send the licensee a notice that sets out the reason for suspension and the day on which the suspension is effective, and the Minister shall</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700667" lims:id="700667"><Label>(a)</Label><Text>reinstate the licence if, within 90 days after the day on which the suspension is effective, the licensee provides the Minister with information or documents demonstrating that the situation giving rise to the suspension did not exist or that it has been corrected; or</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700668" lims:id="700668"><Label>(b)</Label><Text>cancel the licence if, within 90 days after the day on which the suspension is effective, the licensee has not provided the Minister with the information or documents referred to in paragraph (a).</Text></Paragraph></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="700669" lims:id="700669"><Label>42</Label><Text>If the Minister cancels a licence under paragraph 41(b), the Minister shall send the licensee a notice that sets out the reason for the cancellation and the day on which the cancellation is effective.</Text></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700670" lims:id="700670" level="1"><Label>PART 3</Label><TitleText>Good Manufacturing Practices</TitleText></Heading><Heading lims:inforce-start-date="2018-04-04" lims:fid="700671" lims:id="700671" level="2"><TitleText>Prohibition</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2021-03-31" lims:fid="700672" lims:id="700672"><Label>43</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700673" lims:id="700673"><Label>(1)</Label><Text>Subject to subsection (2), no person shall sell a natural health product unless it is manufactured, packaged, labelled, imported, distributed or stored, as the case may be, in accordance with this Part.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700674" lims:id="700674"><Label>(2)</Label><Text>A person may sell a natural health product that is manufactured, packaged, labelled, imported, distributed or stored, as the case may be, in accordance with requirements that are equivalent to those set out in this Part if the natural health product is imported.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2021-03-31" lims:enacted-date="2021-03-18" lims:fid="1290031" lims:id="1290031" lims:enactId="1288932">SOR/2021-46, s. 17(F)</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700675" lims:id="700675" level="2"><TitleText>Specifications</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="700676" lims:id="700676"><Label>44</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700677" lims:id="700677"><Label>(1)</Label><Text>Every natural health product available for sale shall comply with the specifications submitted in respect of that natural health product under paragraph 5(i) and with every change to those specifications made by the product licence holder.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700678" lims:id="700678"><Label>(2)</Label><Text>The specifications shall contain the following information:</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700679" lims:id="700679"><Label>(a)</Label><Text>detailed information respecting the purity of the natural health product, including statements indicating its purity tolerances;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700680" lims:id="700680"><Label>(b)</Label><Text>for each medicinal ingredient of the natural health product, detailed information respecting its quantity per dosage unit and its identity, including statements indicating its quantity and identity tolerances;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700681" lims:id="700681"><Label>(c)</Label><Text>if a representation relating to the potency of a medicinal ingredient is to be shown on a label of the natural health product, detailed information respecting the potency of the medicinal ingredient, including statements indicating its potency tolerances; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700682" lims:id="700682"><Label>(d)</Label><Text>a description of the methods used for testing or examining the natural health product.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700683" lims:id="700683"><Label>(3)</Label><Text>The specifications and every change to those specifications shall be approved by a quality assurance person.</Text></Subsection></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700684" lims:id="700684" level="2"><TitleText>Premises</TitleText><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2018-04-04" lims:fid="700686" lims:id="700686">SOR/2018-69, s. 48(F)</HistoricalNoteSubItem></HistoricalNote></Heading><Section lims:inforce-start-date="2018-04-04" lims:lastAmendedDate="2021-03-31" lims:fid="700687" lims:id="700687"><Label>45</Label><Subsection lims:inforce-start-date="2018-04-04" lims:fid="700688" lims:id="700688"><Label>(1)</Label><Text>Every natural health product shall be manufactured, packaged, labelled and stored in premises that are designed, constructed and maintained in a manner that permits the activity to be conducted under sanitary conditions, and in particular that</Text><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700689" lims:id="700689"><Label>(a)</Label><Text>permits the premises to be kept clean and orderly;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700690" lims:id="700690"><Label>(b)</Label><Text>permits the effective cleaning of all surfaces in the premises;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700691" lims:id="700691"><Label>(c)</Label><Text>permits the natural health product to be stored or processed appropriately;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700692" lims:id="700692"><Label>(d)</Label><Text>prevents the contamination of the natural health product; and</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700693" lims:id="700693"><Label>(e)</Label><Text>prevents the addition of an extraneous substance to the natural health product.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2018-04-04" lims:fid="700694" lims:id="700694"><Label>(2)</Label><Text>Every natural health product shall be stored under conditions that will maintain the quality and safety of the natural health product.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2018-04-04" lims:fid="700696" lims:id="700696">SOR/2018-69, s. 49(F)</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2021-03-31" lims:enacted-date="2021-03-18" lims:fid="1290032" lims:id="1290032" lims:enactId="1288932">SOR/2021-46, s. 17(F)</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2021-03-31" lims:enacted-date="2021-03-18" lims:fid="1290051" lims:id="1290051" lims:enactId="1288951">SOR/2021-46, s. 18(F)</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700697" lims:id="700697" level="2"><TitleText>Equipment</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2021-03-31" lims:fid="700698" lims:id="700698"><Label>46</Label><Text>Every natural health product shall be manufactured, packaged, labelled and stored using equipment that is designed, constructed, maintained, operated and arranged in a manner that</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700699" lims:id="700699"><Label>(a)</Label><Text>permits the effective cleaning of its surfaces;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700700" lims:id="700700"><Label>(b)</Label><Text>permits it to function in accordance with its intended use;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700701" lims:id="700701"><Label>(c)</Label><Text>prevents it from contaminating the natural health product; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700702" lims:id="700702"><Label>(d)</Label><Text>prevents it from adding an extraneous substance to the natural health product.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2021-03-31" lims:enacted-date="2021-03-18" lims:fid="1290034" lims:id="1290034" lims:enactId="1288932">SOR/2021-46, s. 17(F)</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700703" lims:id="700703" level="2"><TitleText>Personnel</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2021-03-31" lims:fid="700704" lims:id="700704"><Label>47</Label><Text>Every natural health product shall be manufactured, packaged, labelled and stored by personnel who are qualified by education, training or experience to perform their respective tasks.</Text><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2021-03-31" lims:enacted-date="2021-03-18" lims:fid="1290036" lims:id="1290036" lims:enactId="1288932">SOR/2021-46, s. 17(F)</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700705" lims:id="700705" level="2"><TitleText>Sanitation Program</TitleText></Heading><Section lims:inforce-start-date="2018-04-04" lims:lastAmendedDate="2021-03-31" lims:fid="700706" lims:id="700706"><Label>48</Label><Text>Every natural health product shall be manufactured, packaged, labelled and stored in accordance with a sanitation program that sets out</Text><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700707" lims:id="700707"><Label>(a)</Label><Text>procedures for effectively cleaning the premises in which the activity is conducted;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700708" lims:id="700708"><Label>(b)</Label><Text>procedures for effectively cleaning the equipment used in the activity;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700709" lims:id="700709"><Label>(c)</Label><Text>procedures for handling any substance used in the activity; and</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700710" lims:id="700710"><Label>(d)</Label><Text>all requirements, in respect of the health, the hygienic behaviour and the clothing of the personnel who are involved in the activity, that are necessary to ensure that the activity is conducted in sanitary conditions.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2018-04-04" lims:fid="700712" lims:id="700712">SOR/2018-69, s. 50(F)</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2021-03-31" lims:enacted-date="2021-03-18" lims:fid="1290037" lims:id="1290037" lims:enactId="1288932">SOR/2021-46, s. 17(F)</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700713" lims:id="700713" level="2"><TitleText>Operations</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2021-03-31" lims:fid="700714" lims:id="700714"><Label>49</Label><Text>Every natural health product shall be manufactured, packaged, labelled and stored in accordance with standard operating procedures that are designed to ensure that the activity is conducted in accordance with the requirements of this Part.</Text><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2021-03-31" lims:enacted-date="2021-03-18" lims:fid="1290039" lims:id="1290039" lims:enactId="1288932">SOR/2021-46, s. 17(F)</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="700715" lims:id="700715"><Label>50</Label><Text>Every manufacturer, packager, labeller, importer and distributor shall establish and maintain a system of control that permits the rapid and complete recall of every lot or batch of the natural health product that has been made available for sale.</Text></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700716" lims:id="700716" level="2"><TitleText>Quality Assurance</TitleText></Heading><Section lims:inforce-start-date="2018-04-04" lims:lastAmendedDate="2022-06-21" lims:fid="700717" lims:id="700717"><Label>51</Label><Subsection lims:inforce-start-date="2018-04-04" lims:fid="700718" lims:id="700718"><Label>(1)</Label><Text>Every manufacturer, packager, labeller, importer and distributor shall</Text><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700719" lims:id="700719"><Label>(a)</Label><Text>have a quality assurance person who</Text><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700720" lims:id="700720"><Label>(i)</Label><Text>is responsible for assuring the quality of the natural health product before it is made available for sale, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700721" lims:id="700721"><Label>(ii)</Label><Text>has training, experience and technical knowledge relating to the activity conducted and the requirements of this Part; and</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700722" lims:id="700722"><Label>(b)</Label><Text>investigate and record every complaint received in respect of the quality of the natural health product and, if necessary, take corrective action.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2018-04-04" lims:fid="700723" lims:id="700723"><Label>(2)</Label><Text>Every natural health product shall be manufactured, packaged and labelled using only material that, prior to its use in the activity, has been approved for that use by a quality assurance person.</Text></Subsection><Subsection lims:inforce-start-date="2018-04-04" lims:fid="700724" lims:id="700724"><Label>(3)</Label><Text>Every natural health product shall be manufactured, packaged, labelled and stored using methods and procedures that, prior to their implementation, have been approved by a quality assurance person.</Text></Subsection><Subsection lims:inforce-start-date="2018-04-04" lims:fid="700725" lims:id="700725"><Label>(4)</Label><Text>Every lot or batch of a natural health product shall be approved by a quality assurance person before it is made available for sale.</Text></Subsection><Subsection lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="700726" lims:id="1362672"><Label>(5)</Label><Text>Every natural health product that is sold and subsequently returned to its manufacturer, packager, labeller, importer or distributor shall be approved by a quality assurance person before that natural health product is made available for further sale.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2018-04-04" lims:fid="700728" lims:id="700728">SOR/2018-69, s. 51(E)</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2021-03-31" lims:enacted-date="2021-03-18" lims:fid="1290040" lims:id="1290040" lims:enactId="1288932">SOR/2021-46, s. 17(F)</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362671" lims:id="1362671" lims:enactId="1358426">SOR/2022-146, s. 8(E)</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700729" lims:id="700729" level="2"><TitleText>Stability Period</TitleText><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2018-04-04" lims:fid="700731" lims:id="700731">SOR/2018-69, s. 52</HistoricalNoteSubItem></HistoricalNote></Heading><Section lims:inforce-start-date="2018-04-04" lims:lastAmendedDate="2021-03-31" lims:fid="700732" lims:id="700732"><Label>52</Label><Text>Every manufacturer and every importer shall determine the period of time during which, after being packaged for sale, the natural health product will maintain its purity and physical characteristics and its medicinal ingredients will maintain their quantity per dosage unit and their potency when</Text><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700733" lims:id="700733"><Label>(a)</Label><Text>it is stored under its recommended storage conditions; or</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700734" lims:id="700734"><Label>(b)</Label><Text>if it does not have recommended storage conditions, it is stored at room temperature.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2018-04-04" lims:fid="700736" lims:id="700736">SOR/2018-69, s. 53</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2021-03-31" lims:enacted-date="2021-03-18" lims:fid="1290041" lims:id="1290041" lims:enactId="1288932">SOR/2021-46, s. 17(F)</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2021-03-31" lims:enacted-date="2021-03-18" lims:fid="1290052" lims:id="1290052" lims:enactId="1288951">SOR/2021-46, s. 18(F)</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700737" lims:id="700737" level="2"><TitleText>Records</TitleText></Heading><Heading lims:inforce-start-date="2018-04-04" lims:fid="700738" lims:id="700738" level="3"><TitleText>Manufacturers</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2022-06-21" lims:fid="700739" lims:id="700739"><Label>53</Label><Text>Every manufacturer who sells a natural health product shall maintain the following records at the site at which the natural health product is manufactured:</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700740" lims:id="700740"><Label>(a)</Label><Text>the master production document for the natural health product;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700741" lims:id="700741"><Label>(b)</Label><Text>a list of all ingredients contained in each lot or batch of the natural health product;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700742" lims:id="700742"><Label>(c)</Label><Text>records of any testing conducted in respect of a lot or batch of raw material used in the manufacture of the natural health product;</Text></Paragraph><Paragraph lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="700743" lims:id="1362673"><Label>(d)</Label><Text>records of any testing conducted by or for the manufacturer in respect of a lot or batch of the natural health product;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700744" lims:id="700744"><Label>(e)</Label><Text>a copy of the specifications for each natural health product that is being manufactured at the site;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700745" lims:id="700745"><Label>(f)</Label><Text>records demonstrating that each lot or batch of the natural health product was manufactured in accordance with the requirements of this Part;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700746" lims:id="700746"><Label>(g)</Label><Text>a record of each determination made by the manufacturer in accordance with section 52 and the information that supports that determination;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700747" lims:id="700747"><Label>(h)</Label><Text>records containing sufficient information to enable the recall of every lot or batch of the natural health product that has been made available for sale;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700748" lims:id="700748"><Label>(i)</Label><Text>a list of all natural health products that are being manufactured at the site; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700749" lims:id="700749"><Label>(j)</Label><Text>a copy of the sanitation program in use at the site.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362675" lims:id="1362675" lims:enactId="1358428">SOR/2022-146, s. 9</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700750" lims:id="700750" level="3"><TitleText>Packagers</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2022-06-21" lims:fid="700751" lims:id="700751"><Label>54</Label><Text>Every packager who sells a natural health product shall maintain the following records at the site at which the natural health product is packaged:</Text><Paragraph lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="700752" lims:id="1362676"><Label>(a)</Label><Text>records of any testing conducted by or for the packager in respect of the material used to package the natural health product;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700753" lims:id="700753"><Label>(b)</Label><Text>records demonstrating that each lot or batch of the natural health product was packaged in accordance with the requirements of this Part;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700754" lims:id="700754"><Label>(c)</Label><Text>records containing sufficient information to enable the recall of every lot or batch of the natural health product that has been made available for sale;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700755" lims:id="700755"><Label>(d)</Label><Text>a list of all natural health products that are being packaged at the site; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700756" lims:id="700756"><Label>(e)</Label><Text>a copy of the sanitation program in use at the site.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362678" lims:id="1362678" lims:enactId="1358430">SOR/2022-146, s. 10</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700757" lims:id="700757" level="3"><TitleText>Labellers</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="700758" lims:id="700758"><Label>55</Label><Text>Every labeller who sells a natural health product shall maintain the following records at the site at which the natural health product is labelled:</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700759" lims:id="700759"><Label>(a)</Label><Text>records demonstrating that each lot or batch of the natural health product was labelled in accordance with the requirements of this Part;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700760" lims:id="700760"><Label>(b)</Label><Text>records containing sufficient information to enable the recall of every lot or batch of the natural health product that has been made available for sale;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700761" lims:id="700761"><Label>(c)</Label><Text>a list of all natural health products that are being labelled at the site; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700762" lims:id="700762"><Label>(d)</Label><Text>a copy of the sanitation program in use at the site.</Text></Paragraph></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700763" lims:id="700763" level="3"><TitleText>Importers</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2022-06-21" lims:fid="700764" lims:id="700764"><Label>56</Label><Text>Every importer who sells a natural health product shall maintain the following records:</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700765" lims:id="700765"><Label>(a)</Label><Text>the master production document for the natural health product;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700766" lims:id="700766"><Label>(b)</Label><Text>a list of all ingredients contained in each lot or batch of the natural health product;</Text></Paragraph><Paragraph lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="700767" lims:id="1362679"><Label>(c)</Label><Text>records of any testing conducted by or for the importer in respect of a lot or batch of the natural health product;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700768" lims:id="700768"><Label>(d)</Label><Text>a copy of the specifications for the natural health product;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700769" lims:id="700769"><Label>(e)</Label><Text>a record of each determination made by the importer in accordance with section 52 and the information that supports that determination;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700770" lims:id="700770"><Label>(f)</Label><Text>records containing sufficient information to enable the recall of every lot or batch of the natural health product that has been made available for sale; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700771" lims:id="700771"><Label>(g)</Label><Text>a copy of the sanitation program in use by the importer.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362681" lims:id="1362681" lims:enactId="1358432">SOR/2022-146, s. 11</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700772" lims:id="700772" level="3"><TitleText>Distributors</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2021-03-31" lims:fid="700773" lims:id="700773"><Label>57</Label><Text>Every distributor shall maintain the following records at the site at which the natural health product is stored:</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700774" lims:id="700774"><Label>(a)</Label><Text>records containing sufficient information to enable the recall of every lot or batch of the natural health product that has been made available for sale;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700775" lims:id="700775"><Label>(b)</Label><Text>a list of all natural health products that are being stored at the site; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700776" lims:id="700776"><Label>(c)</Label><Text>a copy of the sanitation program in use at the site.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2021-03-31" lims:enacted-date="2021-03-18" lims:fid="1290043" lims:id="1290043" lims:enactId="1288932">SOR/2021-46, s. 17(F)</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700777" lims:id="700777" level="3"><TitleText>Record Maintenance</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="700778" lims:id="700778"><Label>58</Label><Text>Every person required under this Part to maintain a record that relates to a lot or batch of a natural health product shall maintain that record for a period of one year following the expiry date of the natural health product to which that record relates.</Text></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700779" lims:id="700779" level="2"><TitleText>Sterile Natural Health Products</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="700780" lims:id="700780"><Label>59</Label><Text>Every natural health product that is intended to be sterile shall be manufactured and packaged</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700781" lims:id="700781"><Label>(a)</Label><Text>in a separate and enclosed area;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700782" lims:id="700782"><Label>(b)</Label><Text>under the supervision of a person trained in microbiology; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700783" lims:id="700783"><Label>(c)</Label><Text>using a method scientifically proven to ensure its sterility.</Text></Paragraph></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700784" lims:id="700784" level="2"><TitleText>Ophthalmic Use</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="700785" lims:id="700785"><Label>60</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700786" lims:id="700786"><Label>(1)</Label><Text>Section C.01.064 of the <XRefExternal reference-type="regulation" link="C.R.C.,_c._870">Food and Drug Regulations</XRefExternal> applies in respect of natural health products except that it shall be read without reference to the words “or parenteral”.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700787" lims:id="700787"><Label>(2)</Label><Text>Section C.01.065 of the <XRefExternal reference-type="regulation" link="C.R.C.,_c._870">Food and Drug Regulations</XRefExternal> applies in respect of natural health products except that it shall be read without reference to</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700788" lims:id="700788"><Label>(a)</Label><Text>the words “or parenteral”; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700789" lims:id="700789"><Label>(b)</Label><Text>the words “or to its common name if there is no proper name”.</Text></Paragraph></Subsection></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700790" lims:id="700790" level="2"><TitleText>Lot or Batch Samples</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="700791" lims:id="700791"><Label>61</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700792" lims:id="700792"><Label>(1)</Label><Text>Subject to subsection (3), if the Minister has reasonable grounds to believe that a lot or batch of a natural health product made available for sale may result in injury to the health of a purchaser or consumer, the Minister may require the manufacturer, importer or distributor to provide a sample of that lot or batch.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700793" lims:id="700793"><Label>(2)</Label><Text>The sample shall be of sufficient quantity to enable a determination of whether the lot or batch of the natural health product complies with the specifications for that natural health product.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700794" lims:id="700794"><Label>(3)</Label><Text>The Minister shall not require a sample of a lot or batch referred to in subsection (1) to be provided if more than one year has elapsed since the expiry date of that natural health product.</Text></Subsection></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700795" lims:id="700795" level="2"><TitleText>Recall Reporting</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2022-06-21" lims:fid="700796" lims:id="700796"><Label>62</Label><Text lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362531" lims:id="1362682">Every manufacturer, importer or distributor who commences a recall of a natural health product shall, within three days after the day on which the recall is commenced, provide the Minister with the following information in respect of the natural health product:</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700797" lims:id="700797"><Label>(a)</Label><Text>the proper name and the common name of each medicinal ingredient that it contains;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700798" lims:id="700798"><Label>(b)</Label><Text>each brand name under which it is sold;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700799" lims:id="700799"><Label>(c)</Label><Text>its product number;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700800" lims:id="700800"><Label>(d)</Label><Text>the number of each lot or batch recalled;</Text></Paragraph><Paragraph lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="700801" lims:id="1362683"><Label>(e)</Label><Text>the name and address of the manufacturer, importer or distributor who commenced the recall;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700802" lims:id="700802"><Label>(f)</Label><Text>the reasons for commencing the recall;</Text></Paragraph><Paragraph lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="700803" lims:id="1362684"><Label>(g)</Label><Text>the name and address of each person to whom the recalled product was sold by the manufacturer, importer or distributor who commenced the recall;</Text></Paragraph><Paragraph lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="700804" lims:id="1362685"><Label>(h)</Label><Text>the quantity of the recalled product that was sold by the manufacturer, importer or distributor who commenced the recall;</Text></Paragraph><Paragraph lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="700805" lims:id="1362686"><Label>(i)</Label><Text>the quantity of the recalled product remaining in the possession of the manufacturer, importer or distributor who commenced the recall;</Text></Paragraph><Paragraph lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="700806" lims:id="1362687"><Label>(j)</Label><Text>if the recall was commenced by a manufacturer, the quantity of the recalled product that they manufactured;</Text></Paragraph><Paragraph lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362688" lims:id="1362688"><Label>(k)</Label><Text>if the recall was commenced by an importer, the quantity of the recalled product that they imported and the name and address of each person that sold it to them;</Text></Paragraph><Paragraph lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362689" lims:id="1362689"><Label>(l)</Label><Text>if the recall was commenced by a distributor, the quantity of the recalled product that was sold to them and the name and address of each person that sold it to them; and</Text></Paragraph><Paragraph lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362690" lims:id="1362690"><Label>(m)</Label><Text>a description of any other action, in respect of the recall, that the manufacturer, importer or distributor who commenced the recall is taking.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362692" lims:id="1362692" lims:enactId="1358434">SOR/2022-146, s. 12</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700807" lims:id="700807" level="1"><Label>PART 4</Label><TitleText>Clinical Trials Involving Human Subjects</TitleText></Heading><Heading lims:inforce-start-date="2018-04-04" lims:fid="700808" lims:id="700808" level="2"><TitleText>Interpretation</TitleText></Heading><Section lims:inforce-start-date="2018-04-04" lims:lastAmendedDate="2018-04-04" lims:fid="700809" lims:id="700809"><Label>63</Label><Text>The following definitions apply in this Part.</Text><Definition lims:inforce-start-date="2018-04-04" lims:fid="700810" lims:id="700810" generate-in-text="no"><Text><DefinedTermEn>adverse event</DefinedTermEn> means any adverse occurrence in the health of a clinical trial subject who is administered a natural health product, that may or may not be caused by the administration of the natural health product, and includes an adverse reaction, a serious adverse reaction and a serious unexpected adverse reaction. (<DefinedTermFr>incident thérapeutique</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2018-04-04" lims:fid="700811" lims:id="700811" generate-in-text="no"><Text><DefinedTermEn>clinical trial</DefinedTermEn> means an investigation in respect of a natural health product that involves human subjects and that is intended to discover or verify its clinical, pharmacological or pharmacodynamic effects, to identify any adverse events that are related to its use, to study its absorption, distribution, metabolism and excretion, or to ascertain its safety or efficacy. (<DefinedTermFr>essai clinique</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2018-04-04" lims:fid="700812" lims:id="700812" generate-in-text="no"><Text><DefinedTermEn>good clinical practices</DefinedTermEn> means generally accepted clinical practices that are designed to ensure the protection of the rights, safety and well-being of clinical trial subjects and other persons, and the good clinical practices referred to in section 74. (<DefinedTermFr>bonnes pratiques cliniques</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2018-04-04" lims:fid="700813" lims:id="700813" generate-in-text="no"><Text><DefinedTermEn>import</DefinedTermEn> means to import a natural health product into Canada for the purpose of sale in a clinical trial. (<DefinedTermFr>importer</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2018-04-04" lims:fid="700814" lims:id="700814" generate-in-text="no"><Text><DefinedTermEn>investigator’s brochure</DefinedTermEn> means a document containing the preclinical and clinical information in respect of the natural health product that is described in paragraph 66(e). (<DefinedTermFr>brochure du chercheur</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2018-04-04" lims:fid="700815" lims:id="700815" generate-in-text="no"><Text><DefinedTermEn>protocol</DefinedTermEn> means a document that describes the objectives, design, methodology, statistical considerations and organization of a clinical trial. (<DefinedTermFr>protocole</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2018-04-04" lims:fid="700816" lims:id="700816" generate-in-text="no"><Text><DefinedTermEn>qualified investigator</DefinedTermEn> means the person responsible to the sponsor for the conduct of the clinical trial at a clinical trial site, who is entitled to provide health care under the laws of the province where the clinical trial site is located and who is</Text><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700817" lims:id="700817"><Label>(a)</Label><Text>in the case of a clinical trial respecting a natural health product to be used for dental purposes only, a physician or dentist and a member in good standing of a professional medical or dental association; and</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700818" lims:id="700818"><Label>(b)</Label><Text>in any other case, a physician and a member in good standing of a professional medical association. (<DefinedTermFr>chercheur qualifié</DefinedTermFr>)</Text></Paragraph></Definition><Definition lims:inforce-start-date="2018-04-04" lims:fid="700819" lims:id="700819" generate-in-text="no"><Text><DefinedTermEn>research ethics board</DefinedTermEn> means a body that is not affiliated with the sponsor, and</Text><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700820" lims:id="700820"><Label>(a)</Label><Text>the principal mandate of which is to approve the initiation of, and conduct periodic reviews of, biomedical research involving human subjects in order to ensure the protection of their rights, safety and well-being; and</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700821" lims:id="700821"><Label>(b)</Label><Text>that has at least five members, that has a majority of members who are Canadian citizens or permanent residents under the <XRefExternal reference-type="act">Immigration Act</XRefExternal>, that is composed of both men and women and that includes at least</Text><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700822" lims:id="700822"><Label>(i)</Label><Text>two members whose primary experience and expertise are in a scientific discipline, who have broad experience in the methods and areas of research to be approved and one of whom is from a medical discipline or, if the clinical trial is in respect of a natural health product to be used for dental purposes only, is from a medical or dental discipline,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700823" lims:id="700823"><Label>(ii)</Label><Text>one member knowledgeable in complementary or alternative health care,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700824" lims:id="700824"><Label>(iii)</Label><Text>one member knowledgeable in ethics,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700825" lims:id="700825"><Label>(iv)</Label><Text>one member knowledgeable in Canadian laws relevant to the research to be approved,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700826" lims:id="700826"><Label>(v)</Label><Text>one member whose primary experience and expertise are in a non-scientific discipline, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700827" lims:id="700827"><Label>(vi)</Label><Text>one member who is from the community or is a representative of an organization interested in the areas of research to be approved and who is not affiliated with the sponsor or the site where the clinical trial is to be conducted. (<DefinedTermFr>comité d’éthique de la recherche</DefinedTermFr>)</Text></Subparagraph></Paragraph></Definition><Definition lims:inforce-start-date="2018-04-04" lims:fid="700828" lims:id="700828" generate-in-text="no"><Text><DefinedTermEn>sponsor</DefinedTermEn> means an individual, corporate body, institution or organization that conducts a clinical trial. (<DefinedTermFr>promoteur</DefinedTermFr>)</Text></Definition><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2018-04-04" lims:fid="700830" lims:id="700830">SOR/2018-69, s. 54(F)</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700831" lims:id="700831" level="2"><TitleText>Application</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="700832" lims:id="700832"><Label>64</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700833" lims:id="700833"><Label>(1)</Label><Text>Subject to subsection (2), this Part applies to the sale or importation of natural health products to be used for the purposes of clinical trials involving human subjects.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700834" lims:id="700834"><Label>(2)</Label><Text>Except for paragraph 65(1)(a), subsection 65(2), section 68, paragraphs 74(a) to (i), subsections 75(1) and 76(1) and (2), paragraphs 76(3)(a) to (d) and (f) to (h), subsection 76(4) and sections 77 and 80 to 83, this Part does not apply to the sale or importation of a natural health product for the purposes of a clinical trial authorized under section 68.</Text></Subsection></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700835" lims:id="700835" level="2"><TitleText>Prohibition</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="700836" lims:id="700836"><Label>65</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700837" lims:id="700837"><Label>(1)</Label><Text>Despite section 4 and subject to subsection (2), no person shall sell or import a natural health product for the purposes of a clinical trial unless</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700838" lims:id="700838"><Label>(a)</Label><Text>the person is authorized under this Part;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700839" lims:id="700839"><Label>(b)</Label><Text>the person complies with this Part and section C.01.064 of the <XRefExternal reference-type="regulation" link="C.R.C.,_c._870">Food and Drug Regulations</XRefExternal>; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700840" lims:id="700840"><Label>(c)</Label><Text>if the natural health product is to be imported, the person has a representative in Canada who is responsible for the sale of the natural health product.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700841" lims:id="700841"><Label>(2)</Label><Text>No person shall sell a natural health product for the purposes of a clinical trial</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700842" lims:id="700842"><Label>(a)</Label><Text>during the period of any suspension of the authorization under section 80 or 81; or</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700843" lims:id="700843"><Label>(b)</Label><Text>after cancellation of the authorization under paragraph 82(b).</Text></Paragraph></Subsection></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700844" lims:id="700844" level="2"><TitleText>Application for Authorization</TitleText></Heading><Section lims:inforce-start-date="2018-04-04" lims:lastAmendedDate="2018-04-04" lims:fid="700845" lims:id="700845"><Label>66</Label><Text>An application by a sponsor for authorization to sell or import a natural health product for the purposes of a clinical trial shall be submitted to the Minister and shall contain the following information and documents:</Text><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700846" lims:id="700846"><Label>(a)</Label><Text>a copy of the protocol for the clinical trial;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700847" lims:id="700847"><Label>(b)</Label><Text>a copy of the statement, as it will be set out in each informed consent form, that states the risks and anticipated benefits arising to the health of clinical trial subjects as a result of their participation in the clinical trial;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700848" lims:id="700848"><Label>(c)</Label><Text>a clinical trial attestation, signed and dated by the sponsor, containing</Text><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700849" lims:id="700849"><Label>(i)</Label><Text>the title of the protocol and the clinical trial number,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700850" lims:id="700850"><Label>(ii)</Label><Text>the brand name or the code for the natural health product,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700851" lims:id="700851"><Label>(iii)</Label><Text>for each medicinal ingredient of the natural health product</Text><Clause lims:inforce-start-date="2018-04-04" lims:fid="700852" lims:id="700852"><Label>(A)</Label><Text>the proper name and common name of the ingredient, and</Text></Clause><Clause lims:inforce-start-date="2018-04-04" lims:fid="700853" lims:id="700853"><Label>(B)</Label><Text>the quantity of the ingredient per dosage unit of the natural health product,</Text></Clause></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700854" lims:id="700854"><Label>(iv)</Label><Text>a qualitative list of the non-medicinal ingredients of the natural health product,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700855" lims:id="700855"><Label>(v)</Label><Text>the dosage form of the natural health product,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700856" lims:id="700856"><Label>(vi)</Label><Text>the name, address and telephone number and, if applicable, the facsimile number and electronic mail address of the sponsor,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700857" lims:id="700857"><Label>(vii)</Label><Text>if the natural health product is to be imported, the name, address and telephone number and, if applicable, the facsimile number and electronic mail address of the sponsor’s representative in Canada who is responsible for the sale of the natural health product,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700858" lims:id="700858"><Label>(viii)</Label><Text>the address of each clinical trial site,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700859" lims:id="700859"><Label>(ix)</Label><Text>for each clinical trial site, the name, address and telephone number and, if applicable, the facsimile number and electronic mail address of the qualified investigator,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700860" lims:id="700860"><Label>(x)</Label><Text>for each clinical trial site, the name, address and telephone number and, if applicable, the facsimile number and electronic mail address of the research ethics board that approved the protocol referred to in paragraph (a) and approved an informed consent form containing the statement referred to in paragraph (b),</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700861" lims:id="700861"><Label>(xi)</Label><Text>for each clinical trial site, the name, address and telephone number and, if applicable, the facsimile number and electronic mail address of any research ethics board that has previously refused to approve the protocol referred to in paragraph (a), its reasons for doing so and the date on which the refusal was given, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700862" lims:id="700862"><Label>(xii)</Label><Text>a statement</Text><Clause lims:inforce-start-date="2018-04-04" lims:fid="700863" lims:id="700863"><Label>(A)</Label><Text>that the clinical trial will be conducted in accordance with good clinical practices and these Regulations, and</Text></Clause><Clause lims:inforce-start-date="2018-04-04" lims:fid="700864" lims:id="700864"><Label>(B)</Label><Text>that all information contained in, or referenced by, the application is complete and accurate and is not false or misleading;</Text></Clause></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700865" lims:id="700865"><Label>(d)</Label><Text>an attestation, signed and dated by the research ethics board for each clinical trial site, that it has reviewed and approved the protocol referred to in paragraph (a) and an informed consent form containing the statement referred to in paragraph (b) and that the board carries out its functions in a manner consistent with good clinical practices;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700866" lims:id="700866"><Label>(e)</Label><Text>an investigator’s brochure that contains the following information, namely,</Text><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700867" lims:id="700867"><Label>(i)</Label><Text>the physical, chemical and, if any, the pharmaceutical properties of the natural health product,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700868" lims:id="700868"><Label>(ii)</Label><Text>the chemistry and manufacturing information of each synthetically manufactured medicinal ingredient of the natural health product,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700869" lims:id="700869"><Label>(iii)</Label><Text>the pharmacological properties of the natural health product, if any, including its metabolites in all animal species tested,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700870" lims:id="700870"><Label>(iv)</Label><Text>the pharmacokinetics of the natural health product and the natural health product metabolism, if any, including the biological transformation of the natural health product in all animal species tested,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700871" lims:id="700871"><Label>(v)</Label><Text>the toxicological effects, if any, in any animal species tested under a single dose study, a repeated dose study or a special study in respect of the natural health product,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700872" lims:id="700872"><Label>(vi)</Label><Text>the results of carcinogenicity studies in any animal species tested in respect of the natural health product, if any,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700873" lims:id="700873"><Label>(vii)</Label><Text>the results of clinical pharmacokinetic studies of the natural health product, if any,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700874" lims:id="700874"><Label>(viii)</Label><Text>the information regarding natural health product safety, pharmacodynamics, efficacy and dose responses of the natural health product that were obtained from previous clinical trials in humans, if any,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700875" lims:id="700875"><Label>(ix)</Label><Text>the known contra-indications for and the precautions to be taken in respect of the natural health product, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700876" lims:id="700876"><Label>(x)</Label><Text>the recommended treatment in the event of an overdose of the natural health product, if any; and</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700877" lims:id="700877"><Label>(f)</Label><Text>the proposed date for the commencement of the clinical trial at each clinical trial site.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2018-04-04" lims:fid="700879" lims:id="700879">SOR/2018-69, s. 55(E)</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700880" lims:id="700880" level="2"><TitleText>Authorization</TitleText></Heading><Section lims:inforce-start-date="2018-04-04" lims:lastAmendedDate="2018-04-04" lims:fid="700881" lims:id="700881"><Label>67</Label><Subsection lims:inforce-start-date="2018-04-04" lims:fid="700882" lims:id="700882"><Label>(1)</Label><Text>The Minister shall authorize a sponsor to sell or import a natural health product for the purposes of a clinical trial if</Text><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700883" lims:id="700883"><Label>(a)</Label><Text>the sponsor submits an application to the Minister that is in accordance with section 66;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700884" lims:id="700884"><Label>(b)</Label><Text>the sponsor provides the Minister with all additional information or samples requested under section 73; and</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700885" lims:id="700885"><Label>(c)</Label><Text>the Minister has reasonable grounds to believe, based on an assessment of the application, an assessment of any samples or information provided under section 73 or a review of any other information that</Text><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700886" lims:id="700886"><Label>(i)</Label><Text>the use of the natural health product for the purposes of the clinical trial will not endanger the health of a clinical trial subject or other person,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700887" lims:id="700887"><Label>(ii)</Label><Text>the clinical trial is not contrary to the best interests of the clinical trial subjects, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700888" lims:id="700888"><Label>(iii)</Label><Text>the objectives of the clinical trial will be achieved.</Text></Subparagraph></Paragraph></Subsection><Subsection lims:inforce-start-date="2018-04-04" lims:fid="700889" lims:id="700889"><Label>(2)</Label><Text>The Minister shall authorize the sponsor to sell or import a natural health product for the purposes of a clinical trial by sending the sponsor a notice of the authorization.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2018-04-04" lims:fid="700891" lims:id="700891">SOR/2018-69, s. 56(F)</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="700892" lims:id="700892"><Label>68</Label><Text>A sponsor is authorized to sell or import a natural health product for the purposes of a clinical trial if the clinical trial is in respect of a recommended use or purpose for which that natural health product is issued a product licence.</Text></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700893" lims:id="700893" level="2"><TitleText>Commencement Notice</TitleText></Heading><Section lims:inforce-start-date="2021-03-31" lims:enacted-date="2021-03-18" lims:lastAmendedDate="2021-03-31" lims:fid="700894" lims:id="1290016"><Label>69</Label><Text>The sponsor shall notify the Minister of the date of the sale or importation of a natural health product for the purposes of a clinical trial at a clinical trial site at least 15 days before the date of that sale or importation.</Text><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2018-04-04" lims:fid="700896" lims:id="700896">SOR/2018-69, s. 57(E)</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2021-03-31" lims:enacted-date="2021-03-18" lims:fid="1290017" lims:id="1290017" lims:enactId="1288927">SOR/2021-46, s. 14(E)</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700897" lims:id="700897" level="2"><TitleText>Notification</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="700898" lims:id="700898"><Label>70</Label><Text>If the sale or importation of a natural health product for the purposes of a clinical trial is authorized under this Part, the sponsor may make one or more of the following changes if the sponsor provides the Minister with notification of the change within 15 days after the day on which the change is made:</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700899" lims:id="700899"><Label>(a)</Label><Text>a change to the information referred to in subparagraph 66(e)(ii) that does not affect the quality or safety of the natural health product; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700900" lims:id="700900"><Label>(b)</Label><Text>a change to the protocol that does not alter the risk to the health of a clinical trial subject, other than a change for which an amendment is required by section 71.</Text></Paragraph></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700901" lims:id="700901" level="2"><TitleText>Amendment</TitleText></Heading><Section lims:inforce-start-date="2018-04-04" lims:lastAmendedDate="2022-06-21" lims:fid="700902" lims:id="700902"><Label>71</Label><Subsection lims:inforce-start-date="2018-04-04" lims:fid="700903" lims:id="700903"><Label>(1)</Label><Text lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362532" lims:id="1362693">Subject to subsection (2), if the sale or importation of a natural health product for the purposes of a clinical trial is authorized under this Part, the sponsor shall not make any of the following amendments unless the authorization is amended accordingly:</Text><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700904" lims:id="700904"><Label>(a)</Label><Text>an amendment to the protocol that affects the selection, monitoring or dismissal of a clinical trial subject;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700905" lims:id="700905"><Label>(b)</Label><Text>an amendment to the protocol that affects the evaluation of the clinical efficacy of the natural health product;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700906" lims:id="700906"><Label>(c)</Label><Text>an amendment to the protocol that alters the risk to the health of a clinical trial subject;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700907" lims:id="700907"><Label>(d)</Label><Text>an amendment to the protocol that affects the safety evaluation of the natural health product;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700908" lims:id="700908"><Label>(e)</Label><Text>an amendment to the protocol that extends the duration of the clinical trial; and</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700909" lims:id="700909"><Label>(f)</Label><Text>an amendment to the information referred to in subparagraph 66(e)(ii) that may affect the safety or quality of that natural health product.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2018-04-04" lims:fid="700910" lims:id="700910"><Label>(2)</Label><Text>If the sponsor is required to immediately make one or more of the amendments referred to in subsection (1) because the clinical trial or the use of the natural health product for the purposes of the clinical trial endangers the health of a clinical trial subject or other person, the sponsor may immediately make the amendment and shall provide the Minister with the information referred to in subsection (3) within 15 days after the day on which the amendment is made.</Text></Subsection><Subsection lims:inforce-start-date="2018-04-04" lims:fid="700911" lims:id="700911"><Label>(3)</Label><Text>An application by the sponsor to amend the authorization for the sale or importation of a natural health product under this Part shall be submitted to the Minister and, in addition to a reference to the application submitted under section 66, shall contain the following information and documents:</Text><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700912" lims:id="700912"><Label>(a)</Label><Text>if as a result of the amendment it is necessary to amend the statement referred to in paragraph 66(b),</Text><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700913" lims:id="700913"><Label>(i)</Label><Text>a copy of the amended statement that indicates the new information, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700914" lims:id="700914"><Label>(ii)</Label><Text>for each clinical trial site, the name, address and telephone number and, if applicable, the facsimile number and electronic mail address of the research ethics board that approved the amended statement;</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700915" lims:id="700915"><Label>(b)</Label><Text>if the application is in respect of an amendment referred to in any of paragraphs (1)(a) to (e),</Text><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700916" lims:id="700916"><Label>(i)</Label><Text>a copy of the amended protocol that indicates the amendment,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700917" lims:id="700917"><Label>(ii)</Label><Text>a copy of the protocol submitted under paragraph 66(a),</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700918" lims:id="700918"><Label>(iii)</Label><Text>the rationale for the amendment,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700919" lims:id="700919"><Label>(iv)</Label><Text>for each clinical trial site, the name, address and telephone number and, if applicable, the facsimile number and electronic mail address of the research ethics board that approved the amended protocol, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700920" lims:id="700920"><Label>(v)</Label><Text>the name, address and telephone number and, if applicable, the facsimile number and electronic mail address of any research ethics board that has previously refused to approve any amendment to the protocol, its reasons for doing so and the date on which the refusal was given;</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700921" lims:id="700921"><Label>(c)</Label><Text>if the application is in respect of an amendment referred to in paragraph (1)(e), a copy of the amended investigator’s brochure or an addendum to the investigator’s brochure that indicates the new information, including supporting toxicological studies and clinical trial safety data, if any; and</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700922" lims:id="700922"><Label>(d)</Label><Text>if the application is in respect of an amendment referred to in paragraph (1)(f), a copy of the amended chemistry and manufacturing information that indicates the amendment, and the rationale for that amendment.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2018-04-04" lims:fid="700923" lims:id="700923"><Label>(4)</Label><Text>The Minister shall amend the authorization to sell or import a natural health product for the purposes of a clinical trial if</Text><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700924" lims:id="700924"><Label>(a)</Label><Text>the sponsor submits an application for amendment to the Minister that is in accordance with subsection (3);</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700925" lims:id="700925"><Label>(b)</Label><Text>the sponsor provides the Minister with all additional information or samples requested under section 73; and</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700926" lims:id="700926"><Label>(c)</Label><Text>the Minister has reasonable grounds to believe, based on an assessment of the application for amendment, an assessment of any samples or information submitted under section 73 or a review of any other information that</Text><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700927" lims:id="700927"><Label>(i)</Label><Text>the use of the natural health product for the purposes of the clinical trial will not endanger the health of a clinical trial subject or other person,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700928" lims:id="700928"><Label>(ii)</Label><Text>the clinical trial is not contrary to the best interests of the clinical trial subjects, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700929" lims:id="700929"><Label>(iii)</Label><Text>the objectives of the clinical trial will be achieved.</Text></Subparagraph></Paragraph></Subsection><Subsection lims:inforce-start-date="2018-04-04" lims:fid="700930" lims:id="700930"><Label>(5)</Label><Text>The Minister shall amend the authorization to sell or import a natural health product for the purposes of a clinical trial by sending the sponsor a notice of the amendment.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2018-04-04" lims:fid="700932" lims:id="700932">SOR/2018-69, s. 58</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362694" lims:id="1362694" lims:enactId="1358441">SOR/2022-146, s. 13(E)</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:lastAmendedDate="2022-06-21" lims:fid="700933" lims:id="1362695"><Label>72</Label><Text>If an authorization to sell or import a natural health product for the purposes of a clinical trial is amended in accordance with subsection 71(5), the sponsor shall sell or import the natural health product and conduct the clinical trial in accordance with the amended authorization.</Text><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362697" lims:id="1362697" lims:enactId="1358443">SOR/2022-146, s. 14</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700938" lims:id="700938" level="2"><TitleText>Additional Information and Samples</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="700939" lims:id="700939"><Label>73</Label><Text>If the information and documents submitted in respect of an application under section 66 or an application for amendment under subsection 71(3) are insufficient to enable the Minister to determine whether the sale or importation of the natural health product should be authorized or whether the authorization should be amended, as the case may be, the Minister may request that the sponsor provide the Minister with samples of the natural health product or additional information relevant to the natural health product or the clinical trial that are necessary to make the determination.</Text></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700940" lims:id="700940" level="2"><TitleText>Sponsor’s Obligations</TitleText></Heading><Heading lims:inforce-start-date="2018-04-04" lims:fid="700941" lims:id="700941" level="3"><TitleText>Good Clinical Practices</TitleText></Heading><Section lims:inforce-start-date="2018-04-04" lims:lastAmendedDate="2021-03-31" lims:fid="700942" lims:id="700942"><Label>74</Label><Text>Every sponsor shall ensure that a clinical trial is conducted in accordance with good clinical practices and, without limiting the generality of the foregoing, shall ensure that</Text><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700943" lims:id="700943"><Label>(a)</Label><Text>the clinical trial is scientifically sound and clearly described in a protocol;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700944" lims:id="700944"><Label>(b)</Label><Text>the clinical trial is conducted, and the natural health product is used, in accordance with the protocol and this Part;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700945" lims:id="700945"><Label>(c)</Label><Text>systems and procedures that assure the quality of every aspect of the clinical trial are implemented;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700946" lims:id="700946"><Label>(d)</Label><Text>for each clinical trial site, the approval of a research ethics board is obtained before the clinical trial begins at the site;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700947" lims:id="700947"><Label>(e)</Label><Text>at each clinical trial site, there is no more than one qualified investigator;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700948" lims:id="700948"><Label>(f)</Label><Text>at each clinical trial site, medical care and medical decisions, in respect of the clinical trial, are under the supervision of the qualified investigator;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700949" lims:id="700949"><Label>(g)</Label><Text>each individual involved in the conduct of the clinical trial is qualified by education, training and experience to perform his or her respective tasks;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700950" lims:id="700950"><Label>(h)</Label><Text>written informed consent, given in accordance with the applicable laws governing consent, is obtained from every person before that person participates in the clinical trial but only after that person has been informed of</Text><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700951" lims:id="700951"><Label>(i)</Label><Text>the risks and anticipated benefits to his or her health arising from participation in the clinical trial, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="700952" lims:id="700952"><Label>(ii)</Label><Text>all other aspects of the clinical trial that are necessary for that person to make the decision to participate in the clinical trial;</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700953" lims:id="700953"><Label>(i)</Label><Text>the requirements respecting information and records set out in section 76 are met; and</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700954" lims:id="700954"><Label>(j)</Label><Text>the natural health product is manufactured and stored in accordance with the requirements set out in Part 3 except for section 61.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2018-04-04" lims:fid="700956" lims:id="700956">SOR/2018-69, s. 59(F)</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2021-03-31" lims:enacted-date="2021-03-18" lims:fid="1290044" lims:id="1290044" lims:enactId="1288932">SOR/2021-46, s. 17(F)</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700957" lims:id="700957" level="3"><TitleText>Labelling</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2021-03-31" lims:fid="700958" lims:id="700958"><Label>75</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700959" lims:id="700959"><Label>(1)</Label><Text>The sponsor shall ensure that the natural health product bears a label that sets out the following information in both official languages:</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700960" lims:id="700960"><Label>(a)</Label><Text>a statement indicating that the natural health product is an investigational natural health product to be used only by a qualified investigator;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700961" lims:id="700961"><Label>(b)</Label><Text>the brand name or code of the natural health product;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700962" lims:id="700962"><Label>(c)</Label><Text>the expiry date of the natural health product;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700963" lims:id="700963"><Label>(d)</Label><Text>the recommended storage conditions for the natural health product, if any;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700964" lims:id="700964"><Label>(e)</Label><Text>the lot number of the natural health product;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700965" lims:id="700965"><Label>(f)</Label><Text>the name and address of the manufacturer;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700966" lims:id="700966"><Label>(g)</Label><Text>the name and address of the sponsor; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700967" lims:id="700967"><Label>(h)</Label><Text>the protocol code or identification.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700968" lims:id="700968"><Label>(2)</Label><Text>Sections 86 to 94 do not apply to a natural health product used for the purposes of a clinical trial.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2021-03-31" lims:enacted-date="2021-03-18" lims:fid="1290054" lims:id="1290054" lims:enactId="1288951">SOR/2021-46, s. 18(F)</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700969" lims:id="700969" level="3"><TitleText>Records</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2022-06-21" lims:fid="700970" lims:id="700970"><Label>76</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700971" lims:id="700971"><Label>(1)</Label><Text>The sponsor shall record, handle and store all information in respect of a clinical trial in a way that allows its complete and accurate reporting as well as its interpretation and verification.</Text></Subsection><Subsection lims:inforce-start-date="2021-03-31" lims:enacted-date="2021-03-18" lims:fid="700972" lims:id="1290020"><Label>(2)</Label><Text>The sponsor shall maintain complete and accurate records to demonstrate that the clinical trial is conducted in accordance with good clinical practices and these Regulations.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700973" lims:id="700973"><Label>(3)</Label><Text>The sponsor shall maintain complete and accurate records in respect of the use of a natural health product in a clinical trial, including</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700974" lims:id="700974"><Label>(a)</Label><Text>a copy of all versions of the investigator’s brochure for the natural health product;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700975" lims:id="700975"><Label>(b)</Label><Text>records respecting each change made to the investigator’s brochure, including the rationale for each change and documentation that supports each change;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700976" lims:id="700976"><Label>(c)</Label><Text>records respecting all adverse events in respect of the natural health product that have occurred inside or outside Canada, including information that specifies the dosage form and the use and purpose of the natural health product at the time of the adverse event;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700977" lims:id="700977"><Label>(d)</Label><Text>records respecting the enrolment of clinical trial subjects, including information sufficient to enable all clinical trial subjects to be identified and contacted in the event that the sale of the natural health product may endanger the health of the clinical trial subjects or other persons;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700978" lims:id="700978"><Label>(e)</Label><Text>records respecting the shipment, receipt, disposition, return and destruction of the natural health product;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700979" lims:id="700979"><Label>(f)</Label><Text>for each clinical trial site, an undertaking from the qualified investigator that is signed and dated by the qualified investigator prior to the commencement of his or her responsibilities in respect of the clinical trial, that states that</Text><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="700980" lims:id="700980"><Label>(i)</Label><Text>the qualified investigator will conduct the clinical trial in accordance with good clinical practices, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="700981" lims:id="700981"><Label>(ii)</Label><Text>the qualified investigator will immediately, on discontinuance of the clinical trial by the sponsor, in its entirety or at a clinical trial site, notify both the clinical trial subjects and the research ethics board of the discontinuance, provide them with the reasons for the discontinuance and advise them in writing of any potential risks to the health of clinical trial subjects or other persons;</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="700982" lims:id="1362699"><Label>(g)</Label><Text>for each clinical trial site, a copy of the protocol, informed consent form and any amendment to the protocol or informed consent form that have been approved by the research ethics board for that clinical trial site;</Text></Paragraph><Paragraph lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="700983" lims:id="1362700"><Label>(h)</Label><Text>for each clinical trial site, an attestation, signed and dated by the research ethics board for that clinical trial site, stating that it has reviewed and approved the protocol and informed consent form and that the board carries out its functions in a manner consistent with good clinical practices; and</Text></Paragraph><Paragraph lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362698" lims:id="1362698"><Label>(i)</Label><Text>for each clinical trial referred to in an application submitted under section 66 or subsection 71(3), the information referred to in subparagraph 66(c)(ix) and paragraph 66(f).</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2022-02-11" lims:enacted-date="2022-02-11" lims:fid="700984" lims:id="1339501"><Label>(4)</Label><Text>The sponsor shall maintain all records referred to in this Part for a period of 15 years.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2021-03-31" lims:enacted-date="2021-03-18" lims:fid="1290019" lims:id="1290019" lims:enactId="1288929">SOR/2021-46, s. 15(E)</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2022-02-11" lims:enacted-date="2022-02-11" lims:fid="1339502" lims:id="1339502" lims:enactId="1339212">SOR/2022-18, s. 56</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362701" lims:id="1362701" lims:enactId="1358445">SOR/2022-146, s. 15</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700985" lims:id="700985" level="3"><TitleText>Submission of Information and Samples</TitleText></Heading><Section lims:inforce-start-date="2018-04-04" lims:lastAmendedDate="2018-04-04" lims:fid="700986" lims:id="700986"><Label>77</Label><Subsection lims:inforce-start-date="2018-04-04" lims:fid="700987" lims:id="700987"><Label>(1)</Label><Text>The Minister shall require a sponsor to provide, within two days after the day on which the request is received, information concerning the natural health product or the clinical trial, or samples of the natural health product, if the Minister has reasonable grounds to believe that</Text><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700988" lims:id="700988"><Label>(a)</Label><Text>the use of the natural health product for the purposes of the clinical trial endangers the health of a clinical trial subject or other person;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700989" lims:id="700989"><Label>(b)</Label><Text>the clinical trial is contrary to the best interests of a clinical trial subject;</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700990" lims:id="700990"><Label>(c)</Label><Text>a qualified investigator is not respecting the undertaking referred to in paragraph 76(3)(f); or</Text></Paragraph><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="700991" lims:id="700991"><Label>(d)</Label><Text>information submitted or provided in respect of the natural health product or the clinical trial is false or misleading.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2018-04-04" lims:fid="700992" lims:id="700992"><Label>(2)</Label><Text>The Minister may require the sponsor to provide, within seven days after the day on which the request is received, any information or records referred to in section 76, or samples of the natural health product, in order to assess the safety of the natural health product or the health of clinical trial subjects or other persons.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2018-04-04" lims:fid="700994" lims:id="700994">SOR/2018-69, s. 60(F)</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="700995" lims:id="700995" level="3"><TitleText>Reaction Reporting</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="700996" lims:id="700996"><Label>78</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="700997" lims:id="700997"><Label>(1)</Label><Text>During the course of a clinical trial, the sponsor shall notify the Minister of any serious adverse reaction and any serious unexpected adverse reaction to the natural health product that has occurred inside Canada as follows:</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700998" lims:id="700998"><Label>(a)</Label><Text>if it is neither fatal nor life threatening, within 15 days after the day on which the sponsor becomes aware of the information; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="700999" lims:id="700999"><Label>(b)</Label><Text>if it is fatal or life threatening, within seven days after the day on which the sponsor becomes aware of the information.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="701000" lims:id="701000"><Label>(2)</Label><Text>The sponsor shall, within eight days after the day on which the Minister is notified under paragraph (1)(b), provide the Minister with a complete report in respect of that information that includes an assessment of the importance and implication of any findings made.</Text></Subsection></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="701001" lims:id="701001" level="3"><TitleText>Discontinuance of a Clinical Trial</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="701002" lims:id="701002"><Label>79</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="701003" lims:id="701003"><Label>(1)</Label><Text>If the sponsor discontinues a clinical trial in its entirety or at a clinical trial site, the sponsor shall</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="701004" lims:id="701004"><Label>(a)</Label><Text>notify the Minister of the discontinuance within 15 days after the day of the discontinuance;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="701005" lims:id="701005"><Label>(b)</Label><Text>provide the Minister with the reason for the discontinuance and its impact on the proposed or ongoing clinical trials in respect of the natural health product conducted in Canada by the sponsor;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="701006" lims:id="701006"><Label>(c)</Label><Text>as soon as possible, notify all qualified investigators of the discontinuance and of the reasons for the discontinuance, and advise them in writing of any potential risks to the health of clinical trial subjects or other persons; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="701007" lims:id="701007"><Label>(d)</Label><Text>in respect of each discontinued clinical trial site, stop the sale or importation of the natural health product as of the day of the discontinuance and take all reasonable measures to ensure the recovery of all unused quantities of the natural health product that have been sold.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="701008" lims:id="701008"><Label>(2)</Label><Text>If the sponsor discontinues a clinical trial in its entirety or at a clinical trial site, the sponsor may resume selling or importing the natural health product for the purposes of the clinical trial in its entirety or at the clinical trial site if, in respect of each clinical trial site where the sale or importation is to be resumed, the sponsor submits to the Minister the information referred to in subparagraphs 66(c)(ix) to (xi) and paragraphs 66(d) and (f).</Text></Subsection></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="701009" lims:id="701009" level="2"><TitleText>Suspension and Cancellation</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2022-06-21" lims:fid="701010" lims:id="701010"><Label>80</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="701011" lims:id="701011"><Label>(1)</Label><Text>Subject to subsection (2), the Minister may suspend the authorization to sell or import a natural health product for the purposes of a clinical trial, in its entirety or at a clinical trial site, if the Minister has reasonable grounds to believe that</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="701012" lims:id="701012"><Label>(a)</Label><Text>the sponsor has contravened these Regulations or any provisions of the Act relating to the natural health product;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="701013" lims:id="701013"><Label>(b)</Label><Text>any information submitted or provided in respect of the natural health product or clinical trial is false or misleading;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="701014" lims:id="701014"><Label>(c)</Label><Text>the sponsor has failed to comply with good clinical practices; or</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="701015" lims:id="701015"><Label>(d)</Label><Text>the sponsor has failed to</Text><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="701016" lims:id="701016"><Label>(i)</Label><Text>provide information or samples of the natural health product as required under section 73 or 77, or</Text></Subparagraph><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="701017" lims:id="701017"><Label>(ii)</Label><Text>notify the Minister or provide a report under section 78.</Text></Subparagraph></Paragraph></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="701018" lims:id="701018"><Label>(2)</Label><Text>Subject to section 81, the Minister shall not suspend the authorization unless</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="701019" lims:id="701019"><Label>(a)</Label><Text>the Minister has sent the sponsor a notice that indicates whether the authorization is intended to be suspended in its entirety or at a clinical trial site and the reason for the intended suspension; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="701020" lims:id="701020"><Label>(b)</Label><Text lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362533" lims:id="1362702">the sponsor has not, within 30 days after the date of the notice referred to in paragraph (a), provided the Minister with information or documents demonstrating that the authorization should not be suspended on the grounds that</Text><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="701021" lims:id="701021"><Label>(i)</Label><Text>the situation giving rise to the intended suspension did not exist, or</Text></Subparagraph><Subparagraph lims:inforce-start-date="2006-03-22" lims:fid="701022" lims:id="701022"><Label>(ii)</Label><Text>the situation giving rise to the intended suspension has been corrected.</Text></Subparagraph></Paragraph></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362704" lims:id="1362704" lims:enactId="1358447">SOR/2022-146, s. 16</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2018-04-04" lims:lastAmendedDate="2018-04-04" lims:fid="701023" lims:id="701023"><Label>81</Label><Text>The Minister shall suspend the authorization to sell or import a natural health product for the purposes of a clinical trial, in its entirety or at a clinical trial site, before giving the sponsor an opportunity to be heard if, as a result of any circumstance, the Minister has reasonable grounds to believe that it is necessary to do so to prevent injury to the health of a clinical trial subject or other person.</Text><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2018-04-04" lims:fid="701025" lims:id="701025">SOR/2018-69, s. 61(F)</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="701026" lims:id="701026"><Label>82</Label><Text>If the Minister suspends the authorization under section 80 or 81, the Minister shall send the sponsor a notice that sets out the reason for the suspension, the day on which the suspension is effective and indicating whether the authorization is suspended in its entirety or at a clinical trial site, and the Minister shall</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="701027" lims:id="701027"><Label>(a)</Label><Text>reinstate the authorization in its entirety or at a clinical trial site, as the case may be, if within 30 days after the day on which the suspension is effective the sponsor provides the Minister with information or documents demonstrating that the situation giving rise to the suspension did not exist or that it has been corrected; or</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="701028" lims:id="701028"><Label>(b)</Label><Text>cancel the authorization in its entirety or at a clinical trial site, as the case may be, if within 30 days after the day on which the suspension is effective the sponsor has not provided the Minister with the information or documents referred to in paragraph (a).</Text></Paragraph></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="701029" lims:id="701029"><Label>83</Label><Text>If the Minister cancels the authorization under paragraph 82(b), the Minister shall send the sponsor a notice that sets out the reason for the cancellation, the day on which the cancellation is effective and indicating whether the authorization is cancelled in its entirety or at a clinical trial site.</Text></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="701030" lims:id="701030" level="1"><Label>PART 5</Label><TitleText>General</TitleText></Heading><Heading lims:inforce-start-date="2018-04-04" lims:fid="701031" lims:id="701031" level="2"><TitleText>Electronic Signatures</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="701032" lims:id="701032"><Label>84</Label><Text>Any signature that is required by these Regulations to be shown on a record or document may be an electronic reproduction of the required signature.</Text></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="701033" lims:id="701033" level="2"><TitleText>Electronic Records</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="701034" lims:id="701034"><Label>85</Label><Text>Any record that is required to be maintained by these Regulations may be maintained in any electronic format from which a printed copy of the record can be produced.</Text></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="701035" lims:id="701035" level="2"><TitleText>Labelling and Packaging</TitleText></Heading><Heading lims:inforce-start-date="2018-04-04" lims:fid="701036" lims:id="701036" level="3"><TitleText>General</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="701037" lims:id="701037"><Label>86</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="701038" lims:id="701038"><Label>(1)</Label><Text>No person shall sell a natural health product unless it is labelled and packaged in accordance with these Regulations.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="701039" lims:id="701039"><Label>(2)</Label><Text>Despite subsection (1), a person may sell a natural health product that is not labelled and packaged in accordance with these Regulations if the sale is to a manufacturer or distributor.</Text></Subsection></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2025-06-21" lims:fid="701040" lims:id="701040"><Label>87</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="701041" lims:id="701041"><Label>(1)</Label><Text lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1362534" lims:id="1532850">If any of the following information is required by these Regulations to be shown on the label of a natural health product, it shall be shown in both English and French:</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="701042" lims:id="701042"><Label>(a)</Label><Text>any of the information referred to in paragraphs (a) to (f) of the definition <DefinedTermEn>recommended conditions of use</DefinedTermEn> in subsection 1(1);</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="701043" lims:id="701043"><Label>(b)</Label><Text>the common name and proper name of each medicinal ingredient and each non-medicinal ingredient that it contains;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="701044" lims:id="701044"><Label>(c)</Label><Text>a description of the source material of a medicinal ingredient; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="701045" lims:id="701045"><Label>(d)</Label><Text>its storage conditions.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="701046" lims:id="1532851"><Label>(2)</Label><Text>Despite subsection (1), if the common name or proper name of a medicinal ingredient or the common name of a non-medicinal ingredient does not have an English or French equivalent and there is an equivalent name in another language, that equivalent name shall be shown.</Text></Subsection><Subsection lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532849" lims:id="1532849"><Label>(3)</Label><Text>Despite subsections (1) and (2), the common name of a non-medicinal ingredient may be replaced by the International Nomenclature Cosmetic Ingredient name assigned to it in the <XRefExternal reference-type="other">International Cosmetic Ingredient Dictionary and Handbook</XRefExternal>, published in Washington, D.C., United States, by the Personal Care Products Council, as amended from time to time.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2021-03-31" lims:enacted-date="2021-03-18" lims:fid="1290056" lims:id="1290056" lims:enactId="1288951">SOR/2021-46, s. 18(F)</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532848" lims:id="1532848" lims:enactId="1358449">SOR/2022-146, s. 17</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2025-06-21" lims:fid="701047" lims:id="701047"><Label>88</Label><Subsection lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532858" lims:id="1532858"><Label>(1)</Label><Text>The statements, information and declarations required by these Regulations to be shown on a label of a natural health product shall be</Text><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532859" lims:id="1532859"><Label>(a)</Label><Text>clearly and prominently displayed;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532860" lims:id="1532860"><Label>(b)</Label><Text>readily discernible to the purchaser or consumer of the natural health product under the customary conditions of purchase and use;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532861" lims:id="1532861"><Label>(c)</Label><Text>in characters of a single colour of type that is a visual equivalent of 100% solid black type on a white background or a uniform neutral background with maximum 5% tint of colour;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532862" lims:id="1532862"><Label>(d)</Label><Text>in characters of a standard sans serif font that is not decorative;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532863" lims:id="1532863"><Label>(e)</Label><Text>in characters that are not in contact with each other or with the features of any tables that are required to be shown under paragraph 93.1(1)(f);</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532864" lims:id="1532864"><Label>(f)</Label><Text>if they relate to a non-medicinal ingredient, in characters of a type size of at least 5.5 points or, if condensed, of at least 5 points; and</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532865" lims:id="1532865"><Label>(g)</Label><Text>if they do not relate to a non-medicinal ingredient, in characters of a type size of at least 6 points or, if condensed, at least 5.5 points.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532866" lims:id="1532866"><Label>(2)</Label><Text>Paragraphs (1)(c) to (g) do not apply to</Text><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532867" lims:id="1532867"><Label>(a)</Label><Text>the lot number, product number or brand name; or</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532868" lims:id="1532868"><Label>(b)</Label><Text>the statements, information and declarations required to be shown on</Text><Subparagraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532869" lims:id="1532869"><Label>(i)</Label><Text>the inner label, if the available surface area for the inner label is 90 cm² or less; or</Text></Subparagraph><Subparagraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532870" lims:id="1532870"><Label>(ii)</Label><Text>the outer label, if the available surface area for the outer label is 90 cm² or less.</Text></Subparagraph></Paragraph></Subsection><Subsection lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532871" lims:id="1532871"><Label>(3)</Label><Text>Paragraphs (1)(c) to (g) do not apply if</Text><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532872" lims:id="1532872"><Label>(a)</Label><Text>the entire quantity of the natural health product is to be used within one day or less in accordance with the directions on the label; or</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532873" lims:id="1532873"><Label>(b)</Label><Text>the immediate container of the natural health product contains no more than three recommended dosage units.</Text></Paragraph></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532853" lims:id="1532853" lims:enactId="1358454">SOR/2022-146, s. 18</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:lastAmendedDate="2025-06-21" lims:fid="701050" lims:id="1532874"><Label>89</Label><Text><Repealed>[Repealed, SOR/2022-146, s. 19]</Repealed></Text></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="701051" lims:id="701051"><Label>90</Label><Text>Every lot number required by these Regulations to be shown on a label of a natural health product shall be preceded by one of the following designations:</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="701052" lims:id="701052"><Label>(a)</Label><Text>“Lot number”;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="701053" lims:id="701053"><Label>(b)</Label><Text>“Lot No.”;</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="701054" lims:id="701054"><Label>(c)</Label><Text>“Lot”; or</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="701055" lims:id="701055"><Label>(d)</Label><Text>“(L)”.</Text></Paragraph></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="701056" lims:id="701056"><Label>91</Label><Text>Every product number required by these Regulations to be shown on a label of a natural health product shall</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="701057" lims:id="701057"><Label>(a)</Label><Text>in the case of a homeopathic medicine, be preceded by the designation “DIN-HM”; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="701058" lims:id="701058"><Label>(b)</Label><Text>in any other case, be preceded by the designation “NPN”.</Text></Paragraph></Section><Section lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:lastAmendedDate="2025-06-21" lims:fid="1532875" lims:id="1532875"><Label>91.1</Label><Text>The requirement in subsection 93.1(11) and paragraphs 93.4(h) and 93.6(1)(h) to show the food allergen source, gluten source and added sulphites statement on a label of a natural health product does not apply if the food allergen, gluten or added sulphites are present in a natural health product as a result of cross-contamination.</Text><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532877" lims:id="1532877" lims:enactId="1358460">SOR/2022-146, s. 20</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:lastAmendedDate="2025-06-21" lims:fid="1532878" lims:id="1532878"><Label>91.2</Label><Text>The source of a food allergen that is required to be shown on a label of a natural health product shall be shown as follows:</Text><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532879" lims:id="1532879"><Label>(a)</Label><Text>for a food allergen from a food referred to in one of paragraphs (a), (b) and (e) of the definition <DefinitionRef>food allergen</DefinitionRef> in subsection 1(1) or derived from that food, by the name of the food as shown in the applicable paragraph;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532880" lims:id="1532880"><Label>(b)</Label><Text>for a food allergen from the food referred to in paragraph (c) of the definition <DefinitionRef>food allergen</DefinitionRef> in subsection 1(1) or derived from that food, by the name “sesame”, “sesame seed” or “sesame seeds”;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532881" lims:id="1532881"><Label>(c)</Label><Text>for a food allergen from a food referred to in one of paragraphs (d) and (f) of the definition <DefinitionRef>food allergen</DefinitionRef> in subsection 1(1) or derived from that food, by the name of the food as shown in the applicable paragraph;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532882" lims:id="1532882"><Label>(d)</Label><Text>for a food allergen from the food referred to in paragraph (g) of the definition <DefinitionRef>food allergen</DefinitionRef> in subsection 1(1) or derived from that food, by the name “soy”, “soya”, “soybean” or “soybeans”;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532883" lims:id="1532883"><Label>(e)</Label><Text>for a food allergen from a food referred to in one of paragraphs (h) to (j) of the definition <DefinitionRef>food allergen</DefinitionRef> in subsection 1(1) or derived from that food, by the common name of the food referred to in item 6, 23 or 24, column 2, of table 1 of the Common Names for Ingredients and Components Document, whichever is applicable; and</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532884" lims:id="1532884"><Label>(f)</Label><Text>for a food allergen from the food referred to in paragraph (k) of the definition <DefinitionRef>food allergen</DefinitionRef> in subsection 1(1) or derived from that food, by the name “mustard”, “mustard seed” or “mustard seeds”.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532886" lims:id="1532886" lims:enactId="1358460">SOR/2022-146, s. 20</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:lastAmendedDate="2025-06-21" lims:fid="1532887" lims:id="1532887"><Label>91.3</Label><Text>The source of gluten that is required to be shown on a label of a natural health product shall be shown as follows:</Text><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532888" lims:id="1532888"><Label>(a)</Label><Text>if the source of gluten is shown in the list of non-medicinal ingredients,</Text><Subparagraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532889" lims:id="1532889"><Label>(i)</Label><Text>for gluten from the grain of a cereal referred to in one of subparagraphs (a)(i) to (v) of the definition <DefinitionRef>gluten</DefinitionRef> in subsection 1(1) or derived from that grain, by the name of the cereal as shown in the applicable subparagraph, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532890" lims:id="1532890"><Label>(ii)</Label><Text>for gluten from the grain of a hybridized strain created from one or more of the cereals referred to in subparagraphs (a)(i) to (v) of the definition <DefinitionRef>gluten</DefinitionRef> in subsection 1(1) or derived from that grain, by the names of the cereals as shown in the applicable subparagraphs; or</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532891" lims:id="1532891"><Label>(b)</Label><Text>if the source of gluten is shown in a food allergen source, gluten source and added sulphites statement, by the name of the cereal in accordance with subparagraph (a)(i) or (ii), in parentheses, immediately following the word “gluten”.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532893" lims:id="1532893" lims:enactId="1358460">SOR/2022-146, s. 20</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:lastAmendedDate="2025-06-21" lims:fid="1532894" lims:id="1532894"><Label>91.4</Label><Text>The added sulphites that are required to be shown on a label of a natural health product shall be shown as follows:</Text><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532895" lims:id="1532895"><Label>(a)</Label><Text>if the added sulphites are shown in the list of non-medicinal ingredients,</Text><Subparagraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532896" lims:id="1532896"><Label>(i)</Label><Text>by the name “sulfites”, “sulfiting agents”, “sulphites” or “sulphiting agents”, or</Text></Subparagraph><Subparagraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532897" lims:id="1532897"><Label>(ii)</Label><Text>individually by the applicable name set out in item 21, column 1, of table 2 of the Common Names for Ingredients and Components Document, except that the name “sodium dithionite”, “sulphur dioxide” or “sulphurous acid” must be followed, in parentheses, by the name “sulfites”, “sulfiting agents”, “sulphites” or “sulphiting agents”; or</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532898" lims:id="1532898"><Label>(b)</Label><Text>if the added sulphites are shown in a food allergen source, gluten source and added sulphites statement, by the name “sulfites”, “sulfiting agents”, “sulphites” or “sulphiting agents”.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532900" lims:id="1532900" lims:enactId="1358460">SOR/2022-146, s. 20</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="701059" lims:id="701059"><Label>92</Label><Text>No reference, direct or indirect, to the Act, the <XRefExternal reference-type="regulation" link="C.R.C.,_c._870">Food and Drug Regulations</XRefExternal> or to these Regulations shall be made on any label of or in any advertisement for a natural health product unless the reference is specifically required by law.</Text></Section><Section lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:lastAmendedDate="2025-06-21" lims:fid="701060" lims:id="1532902"><Label>93</Label><Text>The following information in respect of a natural health product shall be shown on the principal display panel of the inner label and, if there is an outer label, on the principal display panel of the outer label:</Text><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532903" lims:id="1532903"><Label>(a)</Label><Text>its brand name;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532904" lims:id="1532904"><Label>(b)</Label><Text>its product number;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532905" lims:id="1532905"><Label>(c)</Label><Text>its dosage form;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532906" lims:id="1532906"><Label>(d)</Label><Text>if it is sterile, the words “sterile” and “<Language xml:lang="fr">stérile</Language>”; and</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532907" lims:id="1532907"><Label>(e)</Label><Text>the net amount in the immediate container in terms of weight, volume or number.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2018-04-04" lims:fid="701087" lims:id="701087">SOR/2018-69, s. 62</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2021-03-31" lims:enacted-date="2021-03-18" lims:fid="1290057" lims:id="1290057" lims:enactId="1288951">SOR/2021-46, s. 18(F)</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532901" lims:id="1532901" lims:enactId="1358462">SOR/2022-146, s. 21</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:lastAmendedDate="2025-06-21" lims:fid="1532908" lims:id="1532908"><Label>93.1</Label><Subsection lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532909" lims:id="1532909"><Label>(1)</Label><Text>The following information in respect of a natural health product shall be shown on the outer label or, if there is no outer label, on the inner label:</Text><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532910" lims:id="1532910"><Label>(a)</Label><Text>if the product is not imported, the name of the product licence holder;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532911" lims:id="1532911"><Label>(b)</Label><Text>if the product is imported, the name of the product licence holder or importer;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532912" lims:id="1532912"><Label>(c)</Label><Text>its recommended route of administration;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532913" lims:id="1532913"><Label>(d)</Label><Text>its lot number;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532914" lims:id="1532914"><Label>(e)</Label><Text>its expiry date; and</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532915" lims:id="1532915"><Label>(f)</Label><Text>any of the following:</Text><Subparagraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532916" lims:id="1532916"><Label>(i)</Label><Text>a bilingual table entitled “Product Facts / <Language xml:lang="fr">Info-produit</Language>” or “Drug Facts / <Language xml:lang="fr">Info-médicament</Language>”,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532917" lims:id="1532917"><Label>(ii)</Label><Text>two tables, one in English entitled “Product Facts” and one in French entitled “<Language xml:lang="fr">Info-produit</Language>”, or</Text></Subparagraph><Subparagraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532918" lims:id="1532918"><Label>(iii)</Label><Text>two tables, one in English entitled “Drug Facts” and one in French entitled “<Language xml:lang="fr">Info-médicament</Language>”.</Text></Subparagraph></Paragraph></Subsection><Subsection lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532919" lims:id="1532919"><Label>(2)</Label><Text>Any table that is referred to in paragraph (1)(f) shall be shown on the label vertically or horizontally.</Text></Subsection><Subsection lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532920" lims:id="1532920"><Label>(3)</Label><Text>Despite paragraph (1)(f) and subsection (4), the order of the languages in a bilingual table may be reversed.</Text></Subsection><Subsection lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532921" lims:id="1532921"><Label>(4)</Label><Text>A bilingual table shall contain only the following headings in the following order:</Text><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532922" lims:id="1532922"><Label>(a)</Label><Text>“Medicinal ingredients / <Language xml:lang="fr">Ingrédients médicinaux</Language>”;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532923" lims:id="1532923"><Label>(b)</Label><Text>“Uses / <Language xml:lang="fr">Usages</Language>”;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532924" lims:id="1532924"><Label>(c)</Label><Text>“Warnings / <Language xml:lang="fr">Mises en garde</Language>”;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532925" lims:id="1532925"><Label>(d)</Label><Text>“Directions / <Language xml:lang="fr">Mode d’emploi</Language>”;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532926" lims:id="1532926"><Label>(e)</Label><Text>“Other information / <Language xml:lang="fr">Autres renseignements</Language>”;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532927" lims:id="1532927"><Label>(f)</Label><Text>“Non-medicinal ingredients / <Language xml:lang="fr">Ingrédients non médicinaux</Language>”; and</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532928" lims:id="1532928"><Label>(g)</Label><Text>“Questions?”.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532929" lims:id="1532929"><Label>(5)</Label><Text>A table in English shall contain only the following headings in the following order:</Text><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532930" lims:id="1532930"><Label>(a)</Label><Text>“Medicinal ingredients”;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532931" lims:id="1532931"><Label>(b)</Label><Text>“Uses”;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532932" lims:id="1532932"><Label>(c)</Label><Text>“Warnings”;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532933" lims:id="1532933"><Label>(d)</Label><Text>“Directions”;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532934" lims:id="1532934"><Label>(e)</Label><Text>“Other information”;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532935" lims:id="1532935"><Label>(f)</Label><Text>“Non-medicinal ingredients”; and</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532936" lims:id="1532936"><Label>(g)</Label><Text>“Questions?”.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532937" lims:id="1532937"><Label>(6)</Label><Text>A table in French shall contain only the following headings in the following order:</Text><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532938" lims:id="1532938"><Label>(a)</Label><Text>“<Language xml:lang="fr">Ingrédients médicinaux</Language>”;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532939" lims:id="1532939"><Label>(b)</Label><Text>“<Language xml:lang="fr">Usages</Language>”;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532940" lims:id="1532940"><Label>(c)</Label><Text>“<Language xml:lang="fr">Mises en garde</Language>”;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532941" lims:id="1532941"><Label>(d)</Label><Text>“<Language xml:lang="fr">Mode d’emploi</Language>”;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532942" lims:id="1532942"><Label>(e)</Label><Text>“<Language xml:lang="fr">Autres renseignements</Language>”;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532943" lims:id="1532943"><Label>(f)</Label><Text>“<Language xml:lang="fr">Ingrédients non médicinaux</Language>”; and</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532944" lims:id="1532944"><Label>(g)</Label><Text>“<Language xml:lang="fr">Questions?</Language>”.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532945" lims:id="1532945"><Label>(7)</Label><Text>The following information shall be shown under the heading “Medicinal ingredients / <Language xml:lang="fr">Ingrédients médicinaux</Language>” or under the headings “Medicinal ingredients” and “<Language xml:lang="fr">Ingrédients médicinaux</Language>”:</Text><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532946" lims:id="1532946"><Label>(a)</Label><Text>a list of the medicinal ingredients of the natural health product that sets out</Text><Subparagraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532947" lims:id="1532947"><Label>(i)</Label><Text>the proper name of each ingredient or, if the proper name is the chemical name, the common name,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532948" lims:id="1532948"><Label>(ii)</Label><Text>the quantity of each ingredient per dosage unit, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532949" lims:id="1532949"><Label>(iii)</Label><Text>if applicable, the authorized potency of each ingredient; and</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532950" lims:id="1532950"><Label>(b)</Label><Text>a description of the source material of each medicinal ingredient of the natural health product.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532951" lims:id="1532951"><Label>(8)</Label><Text>At least one recommended use or purpose of the natural health product shall be shown under the heading “Uses / <Language xml:lang="fr">Usages</Language>” or under the headings “Uses” and “<Language xml:lang="fr">Usages</Language>”.</Text></Subsection><Subsection lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532952" lims:id="1532952"><Label>(9)</Label><Text>Despite subsections (4), (5), (6) and (8), the recommended use or purpose may be omitted from the table if that information is shown elsewhere on the same label, and, if it is omitted, the heading “Uses / <Language xml:lang="fr">Usages</Language>” or the headings “Uses” and “<Language xml:lang="fr">Usages</Language>” shall also be omitted.</Text></Subsection><Subsection lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532953" lims:id="1532953"><Label>(10)</Label><Text>The risk information, including any cautions, warnings, contra-indications or known adverse reactions associated with the use of the natural health product, shall be shown under the heading “Warnings / <Language xml:lang="fr">Mises en garde</Language>” or under the headings “Warnings” and “<Language xml:lang="fr">Mises en garde</Language>” and, subject to subsections (11) and (12), may be shown in bold type.</Text></Subsection><Subsection lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532954" lims:id="1532954"><Label>(11)</Label><Text>If the natural health product contains a food allergen, gluten or added sulphites, the statement “Allergens / <Language xml:lang="fr">Allergènes</Language>” or the statements “Allergens” and “<Language xml:lang="fr">Allergènes</Language>” shall be shown in bold type under the heading “Warnings / <Language xml:lang="fr">Mises en garde</Language>” or under the headings “Warnings” and “<Language xml:lang="fr">Mises en garde</Language>”, followed by the food allergen source, gluten source and added sulphites statement, also in bold type.</Text></Subsection><Subsection lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532955" lims:id="1532955"><Label>(12)</Label><Text>If the natural health product contains aspartame, the statement “Contains aspartame / <Language xml:lang="fr">Contient de l’aspartame</Language>” or the statements “Contains aspartame” and “<Language xml:lang="fr">Contient de l’aspartame</Language>” shall be shown in bold type under the heading “Warnings / <Language xml:lang="fr">Mises en garde</Language>” or under the headings “Warnings” and “<Language xml:lang="fr">Mises en garde</Language>”.</Text></Subsection><Subsection lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532956" lims:id="1532956"><Label>(13)</Label><Text>Despite subsections (4), (5) and (6), if there is no risk information, including any cautions, warnings, contra-indications or known adverse reactions associated with the use of the natural health product, the heading “Warnings / <Language xml:lang="fr">Mises en garde</Language>” or the headings “Warnings” and “<Language xml:lang="fr">Mises en garde</Language>” shall be omitted from the table.</Text></Subsection><Subsection lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532957" lims:id="1532957"><Label>(14)</Label><Text>The following information in respect of the natural health product shall be shown under the headings “Directions / <Language xml:lang="fr">Mode d’emploi</Language>” or under the headings “Directions” and “<Language xml:lang="fr">Mode d’emploi</Language>”:</Text><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532958" lims:id="1532958"><Label>(a)</Label><Text>the recommended dose; and</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532959" lims:id="1532959"><Label>(b)</Label><Text>the recommended duration of use, if any.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532960" lims:id="1532960"><Label>(15)</Label><Text>The recommended storage conditions of the natural health product shall be shown under the heading “Other information / <Language xml:lang="fr">Autres renseignements</Language>” or under the headings “Other information” and “<Language xml:lang="fr">Autres renseignements</Language>”.</Text></Subsection><Subsection lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532961" lims:id="1532961"><Label>(16)</Label><Text>Despite subsections (4), (5), (6) and (15), the recommended storage conditions may be omitted from the table if they are shown elsewhere on the same label, and, if they are omitted and no information is to be included under the heading “Other information / <Language xml:lang="fr">Autres renseignements</Language>” or the headings “Other information” and “<Language xml:lang="fr">Autres renseignements</Language>”, the heading or headings shall also be omitted.</Text></Subsection><Subsection lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532962" lims:id="1532962"><Label>(17)</Label><Text>The following information shall be shown under the heading “Non-medicinal ingredients / <Language xml:lang="fr">Ingrédients non médicinaux</Language>” or under the headings “Non-medicinal ingredients” and “<Language xml:lang="fr">Ingrédients non médicinaux</Language>”:</Text><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532963" lims:id="1532963"><Label>(a)</Label><Text>a qualitative list, by common name, of the non-medicinal ingredients of the natural health product; and</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532964" lims:id="1532964"><Label>(b)</Label><Text>if the natural health product contains mercury or any salts or derivatives of mercury as a non-medicinal ingredient, a statement that sets out the quantities of those ingredients.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532965" lims:id="1532965"><Label>(18)</Label><Text>The telephone number, email address or website address of a contact person who represents the product licence holder of the natural health product shall be shown under the heading “Questions?”.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532967" lims:id="1532967" lims:enactId="1358462">SOR/2022-146, s. 21</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:lastAmendedDate="2025-06-21" lims:fid="1532968" lims:id="1532968"><Label>93.2</Label><Text>The following requirements apply in respect of a table referred to in paragraph 93.1(1)(f):</Text><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532969" lims:id="1532969"><Label>(a)</Label><Text>the title shall be separated by a solid black line from the other information in the table;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532970" lims:id="1532970"><Label>(b)</Label><Text>each heading and the information that is shown under it shall be separated by a solid black line from any subsequent heading;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532971" lims:id="1532971"><Label>(c)</Label><Text>the type size of the characters of the title shall be larger than that of each heading;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532972" lims:id="1532972"><Label>(d)</Label><Text>the type size of the characters of each heading shall be larger than that of the information that is shown under each heading;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532973" lims:id="1532973"><Label>(e)</Label><Text>the title and the headings shall be in bold type;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532974" lims:id="1532974"><Label>(f)</Label><Text>the information that is shown under each heading shall be in regular type, except as otherwise provided; and</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532975" lims:id="1532975"><Label>(g)</Label><Text>the title, the headings and the information that is shown under each heading shall all be shown in the same font type.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532977" lims:id="1532977" lims:enactId="1358462">SOR/2022-146, s. 21</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:lastAmendedDate="2025-06-21" lims:fid="1532978" lims:id="1532978"><Label>93.3</Label><Subsection lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532979" lims:id="1532979"><Label>(1)</Label><Text>If, despite the following measures, the available surface area for a label is insufficient to accommodate all of the information that is required to be shown in a table under section 93.1, the information required to be shown under subsection 93.1(17) shall be shown elsewhere on the same label:</Text><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532980" lims:id="1532980"><Label>(a)</Label><Text>the use of a bilingual table;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532981" lims:id="1532981"><Label>(b)</Label><Text>the use of condensed characters of a type size of at least 5 points to show information that is related to non-medicinal ingredients; and</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532982" lims:id="1532982"><Label>(c)</Label><Text>the use of condensed characters of a type size of at least 5.5 points to show information that is not related to non-medicinal ingredients.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532983" lims:id="1532983"><Label>(2)</Label><Text>If, despite the application of subsection (1), the available surface area for the label is insufficient to accommodate all of the remaining information that is required to be shown in the table, the information required to be shown under subsection 93.1(17) shall be shown</Text><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532984" lims:id="1532984"><Label>(a)</Label><Text>in a leaflet that is affixed or attached to the outermost container of the natural health product;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532985" lims:id="1532985"><Label>(b)</Label><Text>in a package insert; or</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532986" lims:id="1532986"><Label>(c)</Label><Text>on a website.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532987" lims:id="1532987"><Label>(3)</Label><Text>If, despite the application of subsection (2), the available surface area for the label is insufficient to accommodate all of the remaining information that is required to be shown in the table, the information required to be shown under paragraph 93.1(7)(b) shall be shown in the leaflet or package insert, or on the website, that contains the information required to be shown under subsection 93.1(17).</Text></Subsection><Subsection lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532988" lims:id="1532988"><Label>(4)</Label><Text>For the purposes of subsections (1), (2) and (3), the table shall include a statement under the title “Product Facts / <Language xml:lang="fr">Info-produit</Language>” or “Product Facts” and “<Language xml:lang="fr">Info-produit</Language>” that indicates where the information required to be shown under subsection 93.1(17), and, if applicable, paragraph 93.1(7)(b), can be found.</Text></Subsection><Subsection lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532989" lims:id="1532989"><Label>(5)</Label><Text>The information that is required to be shown in a package insert or on a website shall appear in a table that complies with the requirements of sections 93.1 and 93.2.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532991" lims:id="1532991" lims:enactId="1358462">SOR/2022-146, s. 21</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:lastAmendedDate="2025-06-21" lims:fid="1532992" lims:id="1532992"><Label>93.4</Label><Text>If a natural health product has both an inner and outer label, the following information in respect of the product shall be shown on the inner label:</Text><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532993" lims:id="1532993"><Label>(a)</Label><Text>if the product is not imported, the name of the product licence holder and the telephone number, email address or website address of the contact person who represents the product licence holder;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532994" lims:id="1532994"><Label>(b)</Label><Text>if the product is imported, the name of the product licence holder or importer and the telephone number, email address or website address of the contact person who represents the product licence holder or importer;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532995" lims:id="1532995"><Label>(c)</Label><Text>a list of its medicinal ingredients that sets out</Text><Subparagraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532996" lims:id="1532996"><Label>(i)</Label><Text>the proper name of each ingredient or, if the proper name is the chemical name, the common name,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532997" lims:id="1532997"><Label>(ii)</Label><Text>the quantity of each ingredient per dosage unit, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532998" lims:id="1532998"><Label>(iii)</Label><Text>if applicable, the authorized potency of each ingredient;</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1532999" lims:id="1532999"><Label>(d)</Label><Text>at least one of its recommended uses or purposes;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533000" lims:id="1533000"><Label>(e)</Label><Text>its recommended route of administration;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533001" lims:id="1533001"><Label>(f)</Label><Text>its recommended dose;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533002" lims:id="1533002"><Label>(g)</Label><Text>its recommended duration of use, if any;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533003" lims:id="1533003"><Label>(h)</Label><Text>if it contains a food allergen, gluten or added sulphites, the statement “Allergens / <Language xml:lang="fr">Allergènes</Language>” or the statements “Allergens” and “<Language xml:lang="fr">Allergènes</Language>” in bold type, followed by the food allergen source, gluten source and added sulphites statement, also in bold type;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533004" lims:id="1533004"><Label>(i)</Label><Text>if it contains aspartame, the statement “Contains aspartame / <Language xml:lang="fr">Contient de l’aspartame</Language>” or the statements “Contains aspartame” and “<Language xml:lang="fr">Contient de l’aspartame</Language>” in bold type;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533005" lims:id="1533005"><Label>(j)</Label><Text>any other risk information, including any cautions, warnings, contra-indications or known adverse reactions associated with its use;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533006" lims:id="1533006"><Label>(k)</Label><Text>its recommended storage conditions, if any;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533007" lims:id="1533007"><Label>(l)</Label><Text>its lot number; and</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533008" lims:id="1533008"><Label>(m)</Label><Text>its expiry date.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533010" lims:id="1533010" lims:enactId="1358462">SOR/2022-146, s. 21</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:lastAmendedDate="2025-06-21" lims:fid="1533011" lims:id="1533011"><Label>93.5</Label><Text>Sections 93.1 to 93.4 do not apply in respect of a natural health product if</Text><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533012" lims:id="1533012"><Label>(a)</Label><Text>the available surface area for the outer label — or, if there is no outer label, for the inner label — is 90 cm² or less;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533013" lims:id="1533013"><Label>(b)</Label><Text>the entire quantity of the product is to be used within one day or less in accordance with the directions on the label;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533014" lims:id="1533014"><Label>(c)</Label><Text>the immediate container contains no more than three recommended dosage units; or</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533015" lims:id="1533015"><Label>(d)</Label><Text>the product has a localized effect and is</Text><Subparagraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533016" lims:id="1533016"><Label>(i)</Label><Text>recommended to be used in the oral cavity or on the skin,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533017" lims:id="1533017"><Label>(ii)</Label><Text>recommended for aromatherapy,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533018" lims:id="1533018"><Label>(iii)</Label><Text>recommended for organotherapy,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533019" lims:id="1533019"><Label>(iv)</Label><Text>a throat lozenge,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533020" lims:id="1533020"><Label>(v)</Label><Text>a topical nasal decongestant or counterirritant, or</Text></Subparagraph><Subparagraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533021" lims:id="1533021"><Label>(vi)</Label><Text>a flower essence.</Text></Subparagraph></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533023" lims:id="1533023" lims:enactId="1358462">SOR/2022-146, s. 21</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:lastAmendedDate="2025-06-21" lims:fid="1533024" lims:id="1533024"><Label>93.6</Label><Subsection lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533025" lims:id="1533025"><Label>(1)</Label><Text>If any of the conditions set out in section 93.5 is met, the following information in respect of the natural health product shall be shown on the inner label and, if there is an outer label, on the outer label:</Text><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533026" lims:id="1533026"><Label>(a)</Label><Text>if the product is not imported, the name of the product licence holder and the telephone number, email address or website address of a contact person who represents the product licence holder;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533027" lims:id="1533027"><Label>(b)</Label><Text>if the product is imported, the name of the product licence holder or importer and the telephone number, email address or website address of a contact person who represents the product licence holder or importer;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533028" lims:id="1533028"><Label>(c)</Label><Text>a list of its medicinal ingredients that sets out</Text><Subparagraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533029" lims:id="1533029"><Label>(i)</Label><Text>the proper name of each ingredient or, if the proper name is the chemical name, the common name,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533030" lims:id="1533030"><Label>(ii)</Label><Text>the quantity of each ingredient per dosage unit, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533031" lims:id="1533031"><Label>(iii)</Label><Text>if applicable, the authorized potency of each ingredient;</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533032" lims:id="1533032"><Label>(d)</Label><Text>at least one of its recommended uses or purposes;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533033" lims:id="1533033"><Label>(e)</Label><Text>its recommended route of administration;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533034" lims:id="1533034"><Label>(f)</Label><Text>its recommended dose;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533035" lims:id="1533035"><Label>(g)</Label><Text>its recommended duration of use, if any;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533036" lims:id="1533036"><Label>(h)</Label><Text>if it contains a food allergen, gluten or added sulphites, the statement “Allergens / <Language xml:lang="fr">Allergènes</Language>” or the statements “Allergens” and “<Language xml:lang="fr">Allergènes</Language>” in bold type, followed by the food allergen source, gluten source and added sulphites statement, also in bold type;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533037" lims:id="1533037"><Label>(i)</Label><Text>if it contains aspartame, the statement “Contains aspartame / <Language xml:lang="fr">Contient de l’aspartame</Language>” or the statements “Contains aspartame” and “<Language xml:lang="fr">Contient de l’aspartame</Language>” in bold type;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533038" lims:id="1533038"><Label>(j)</Label><Text>any other risk information, including any cautions, warnings, contra-indications or known adverse reactions associated with its use;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533039" lims:id="1533039"><Label>(k)</Label><Text>its recommended storage conditions, if any;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533040" lims:id="1533040"><Label>(l)</Label><Text>its lot number; and</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533041" lims:id="1533041"><Label>(m)</Label><Text>its expiry date.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533042" lims:id="1533042"><Label>(2)</Label><Text>Subject to subsections (3) and (4), if any of the conditions set out in section 93.5 is met, the following information in respect of the natural health product shall be shown on the outer label or, if there is no outer label, on the inner label:</Text><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533043" lims:id="1533043"><Label>(a)</Label><Text>a qualitative list, by common name, of the non-medicinal ingredients that it contains;</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533044" lims:id="1533044"><Label>(b)</Label><Text>if it contains mercury or any salts or derivatives of mercury as a non-medicinal ingredient, a statement that sets out the quantities of those ingredients; and</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533045" lims:id="1533045"><Label>(c)</Label><Text>a description of the source material of each medicinal ingredient that it contains.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533046" lims:id="1533046"><Label>(3)</Label><Text>The information referred to in paragraphs (2)(a) and (b) shall be shown in a leaflet that is affixed or attached to the outermost container of the natural health product, in a package insert or on a website if</Text><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533047" lims:id="1533047"><Label>(a)</Label><Text>in the case described in paragraph 93.5(d), the available surface area for the label is insufficient to accommodate the information that is required to be shown under subsections (1) and (2), despite the use of the following:</Text><Subparagraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533048" lims:id="1533048"><Label>(i)</Label><Text>condensed characters of a type size of at least 5 points for information that is related to non-medicinal ingredients; and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533049" lims:id="1533049"><Label>(ii)</Label><Text>condensed characters of a type size of at least 5.5 points for information that is not related to non-medicinal ingredients; and</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533050" lims:id="1533050"><Label>(b)</Label><Text>in all other cases, the available surface area for the label is insufficient to accommodate the information that is required to be shown under subsections (1) and (2).</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533051" lims:id="1533051"><Label>(4)</Label><Text>If, despite the application of subsection (3), the available surface area for the label is insufficient to accommodate all of the remaining information that is required to be shown under subsections (1) and (2), the information referred to in paragraph (2)(c) shall be shown in the leaflet or package insert, or on the website, that contains the information referred to in paragraphs (2)(a) and (b).</Text></Subsection><Subsection lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533052" lims:id="1533052"><Label>(5)</Label><Text>For the purposes of subsections (3) and (4), the label shall include a statement that indicates where the information referred to in paragraphs (2)(a) and (b), and, if applicable, paragraph (2)(c), can be found.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533054" lims:id="1533054" lims:enactId="1358462">SOR/2022-146, s. 21</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="701088" lims:id="701088" level="3"><TitleText>Small Package Labelling</TitleText></Heading><Section lims:inforce-start-date="2018-04-04" lims:lastAmendedDate="2025-06-21" lims:fid="701089" lims:id="701089"><Label>94</Label><Subsection lims:inforce-start-date="2018-04-04" lims:fid="701090" lims:id="701090"><Label>(1)</Label><Text lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1362536" lims:id="1533056">If the immediate container of a natural health product is not large enough to accommodate an inner label that complies with the relevant requirements of sections 93 to 93.6, the product shall be labelled as follows:</Text><Paragraph lims:inforce-start-date="2018-04-04" lims:fid="701091" lims:id="701091"><Label>(a)</Label><Text>the inner label shall show the following in respect of the natural health product, namely,</Text><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="701092" lims:id="701092"><Label>(i)</Label><Text>a brand name,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="701093" lims:id="1533057"><Label>(ii)</Label><Text>a qualitative list of its medicinal ingredients, by proper name, or by common name if the proper name is the chemical name, in descending order of quantity per dosage unit,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="701094" lims:id="701094"><Label>(iii)</Label><Text>its recommended dose,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="701095" lims:id="701095"><Label>(iv)</Label><Text>its recommended duration of use, if any,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="701096" lims:id="701096"><Label>(v)</Label><Text>its lot number,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="701097" lims:id="701097"><Label>(vi)</Label><Text>its expiry date,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="701098" lims:id="701098"><Label>(vii)</Label><Text>its product number,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="701099" lims:id="701099"><Label>(viii)</Label><Text>if it is sterile, the words “sterile” and “<Language xml:lang="fr">stérile</Language>”,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="701100" lims:id="701100"><Label>(ix)</Label><Text>the net amount in the immediate container in terms of weight, measure or number,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="701101" lims:id="701101"><Label>(x)</Label><Text>its recommended use or purpose, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2018-04-04" lims:fid="701102" lims:id="701102"><Label>(xi)</Label><Text>if it does not have an outer label, a statement that refers the purchaser or consumer to the leaflet that is required in accordance with subsection (2); and</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="701103" lims:id="1533058"><Label>(b)</Label><Text>the outer label, if any, shall comply with the relevant requirements of sections 93 to 93.6.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="701104" lims:id="1533059"><Label>(2)</Label><Text>If the natural health product does not have an outer label,</Text><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533060" lims:id="1533060"><Label>(a)</Label><Text>the statements, information and declarations that would, but for subsection (1), be required to be shown on the inner label shall be shown in a leaflet that is affixed or attached to the immediate container; and</Text></Paragraph><Paragraph lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533061" lims:id="1533061"><Label>(b)</Label><Text>if section 93.1 applies to the product, the tables required under that section, including the information in them, shall be shown in the leaflet in the manner described in that section and in section 93.2.</Text></Paragraph></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2018-04-04" lims:fid="701106" lims:id="701106">SOR/2018-69, s. 63</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2025-06-21" lims:enacted-date="2022-06-21" lims:fid="1533055" lims:id="1533055" lims:enactId="1358464">SOR/2022-146, s. 22</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="701107" lims:id="701107" level="3"><TitleText>Security Packaging</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2022-06-21" lims:fid="701108" lims:id="701108"><Label>95</Label><Subsection lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="701109" lims:id="1362705"><Label>(1)</Label><Text>Subject to subsection (2), no person shall sell or import one or more of the following natural health products that is packaged unless it is contained in a security package:</Text><Paragraph lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362706" lims:id="1362706"><Label>(a)</Label><Text>a mouthwash;</Text></Paragraph><Paragraph lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362707" lims:id="1362707"><Label>(b)</Label><Text>a product to be inhaled, ingested or inserted into the body; or</Text></Paragraph><Paragraph lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362708" lims:id="1362708"><Label>(c)</Label><Text>a product for ophthalmic use.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="701110" lims:id="701110"><Label>(2)</Label><Text>Subsection (1) does not apply to lozenges.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="701111" lims:id="701111"><Label>(3)</Label><Text>Subject to subsection (4), a statement or illustration that draws attention to the security feature of the security package referred to in subsection (1) shall be shown</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="701112" lims:id="701112"><Label>(a)</Label><Text>on the inner label; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="701113" lims:id="701113"><Label>(b)</Label><Text>if the security feature is a part of the outer package, on the outer label.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="701114" lims:id="701114"><Label>(4)</Label><Text>Subsection (3) does not apply if the security feature of a security package is self-evident and is an integral part of the immediate container.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2022-06-21" lims:enacted-date="2022-06-21" lims:fid="1362710" lims:id="1362710" lims:enactId="1358473">SOR/2022-146, s. 23</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="701115" lims:id="701115" level="3"><TitleText>Pressurized Containers</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="701116" lims:id="701116"><Label>96</Label><Text>Sections A.01.061 to A.01.063 of the <XRefExternal reference-type="regulation" link="C.R.C.,_c._870">Food and Drug Regulations</XRefExternal> apply in respect of natural health products.</Text></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="701117" lims:id="701117" level="3"><TitleText>Cautionary Statements and Child Resistant Packages</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="701118" lims:id="701118"><Label>97</Label><Text>Subsections C.01.001(2) to (4) and C.01.028(1), paragraphs C.01.028(2)(b) and (c), section C.01.029, subsection C.01.031(1), paragraphs C.01.031.2(1)(a) and (c) to (g), subsection C.01.031.2(2), and paragraphs C.01.031.2(3)(a) and (c) of the <XRefExternal reference-type="regulation" link="C.R.C.,_c._870">Food and Drug Regulations</XRefExternal> apply in respect of natural health products.</Text></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="701119" lims:id="701119" level="3"><TitleText>Medicinal Ingredient Representations</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="701120" lims:id="701120"><Label>98</Label><Text>Section C.01.012 of the <XRefExternal reference-type="regulation" link="C.R.C.,_c._870">Food and Drug Regulations</XRefExternal> applies in respect of natural health products.</Text></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="701121" lims:id="701121" level="2"><TitleText>Inspectors</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="701122" lims:id="701122"><Label>99</Label><Text>Sections A.01.022 to A.01.026 of the <XRefExternal reference-type="regulation" link="C.R.C.,_c._870">Food and Drug Regulations</XRefExternal> apply in respect of natural health products.</Text></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="701123" lims:id="701123" level="2"><TitleText>Imported Natural Health Products</TitleText></Heading><Section lims:inforce-start-date="2018-04-04" lims:lastAmendedDate="2018-04-04" lims:fid="701124" lims:id="701124"><Label>100</Label><Text>Sections A.01.040 to A.01.044 of the <XRefExternal reference-type="regulation" link="C.R.C.,_c._870">Food and Drug Regulations</XRefExternal> apply in respect of natural health products.</Text><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2018-04-04" lims:fid="701126" lims:id="701126">SOR/2018-69, s. 64</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="701127" lims:id="701127" level="2"><TitleText>Export Certificates</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="701128" lims:id="701128"><Label>101</Label><Text>Section A.01.045 of the <XRefExternal reference-type="regulation" link="C.R.C.,_c._870">Food and Drug Regulations</XRefExternal> and Appendix III to those Regulations apply in respect of natural health products.</Text></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="701129" lims:id="701129" level="2"><TitleText>Sampling of Articles</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="701130" lims:id="701130"><Label>102</Label><Text>Sections A.01.050 and A.01.051 of the <XRefExternal reference-type="regulation" link="C.R.C.,_c._870">Food and Drug Regulations</XRefExternal> apply in respect of natural health products.</Text></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="701131" lims:id="701131" level="2"><TitleText>Tablet Disintegration Times</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="701132" lims:id="701132"><Label>103</Label><Text>Subsection C.01.015(1) and paragraphs C.01.015(2)(d) to (f) of the <XRefExternal reference-type="regulation" link="C.R.C.,_c._870">Food and Drug Regulations</XRefExternal> apply in respect of natural health products.</Text></Section><Heading lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="701133" lims:id="1261680" level="2"><TitleText>Sale of Natural Health Product for Emergency Treatment</TitleText><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261682" lims:id="1261682" lims:enactId="1261137">SOR/2020-212, s. 3(F)</HistoricalNoteSubItem></HistoricalNote></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2023-11-24" lims:fid="701134" lims:id="701134"><Label>103.1</Label><Text lims:inforce-start-date="2023-11-24" lims:enacted-date="2023-11-24" lims:fid="1261197" lims:id="1429308">Section C.08.010 and subsections C.08.011(1) and (3) of the <XRefExternal reference-type="regulation" link="C.R.C.,_c._870">Food and Drug Regulations</XRefExternal> apply in respect of natural health products with the following modifications:</Text><Paragraph lims:inforce-start-date="2023-11-24" lims:enacted-date="2023-11-24" lims:fid="701135" lims:id="1429311"><Label>(a)</Label><Text>a reference to “new drug” is to be read as a reference to “natural health product”;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-11-24" lims:enacted-date="2023-11-24" lims:fid="701136" lims:id="1429312"><Label>(b)</Label><Text>the sale of a natural health product can only be authorized for human use;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-11-24" lims:enacted-date="2023-11-24" lims:fid="1261686" lims:id="1429313"><Label>(c)</Label><Text>in subparagraph C.08.010(1)(b)(i), the reference to “adverse drug reactions” is to be read as a reference to “adverse reactions”;</Text></Paragraph><Paragraph lims:inforce-start-date="2023-11-24" lims:enacted-date="2023-11-24" lims:fid="1261687" lims:id="1429314"><Label>(d)</Label><Text>paragraph C.08.010(2)(c) is to be read as follows:</Text><ReadAsText lims:inforce-start-date="2023-11-24" lims:enacted-date="2023-11-24" lims:fid="1429315" lims:id="1429315"><SectionPiece lims:inforce-start-date="2023-11-24" lims:enacted-date="2023-11-24" lims:fid="1429316" lims:id="1429316"><Paragraph lims:inforce-start-date="2023-11-24" lims:enacted-date="2023-11-24" lims:fid="1429317" lims:id="1429317"><Label>(c)</Label><Text>the Minister has not, in respect of a natural health product, suspended the product licence under subsection 18(1) or section 19 of the <XRefExternal reference-type="regulation" link="SOR-2003-196">Natural Health Products Regulations</XRefExternal> or cancelled the product licence under paragraph 20(b) of those Regulations;</Text></Paragraph></SectionPiece></ReadAsText></Paragraph><Paragraph lims:inforce-start-date="2023-11-24" lims:enacted-date="2023-11-24" lims:fid="1429309" lims:id="1429309"><Label>(e)</Label><Text>in subsection C.08.011(1), the reference to “section C.08.002” is to be read as a reference to “subsection 4(1) of the <XRefExternal reference-type="regulation" link="SOR-2003-196">Natural Health Products Regulations</XRefExternal>”; and</Text></Paragraph><Paragraph lims:inforce-start-date="2023-11-24" lims:enacted-date="2023-11-24" lims:fid="1429310" lims:id="1429310"><Label>(f)</Label><Text>in subsection C.08.011(3), the reference to “these Regulations” is to be read as a reference to the <XRefExternal reference-type="regulation" link="SOR-2003-196">Natural Health Products Regulations</XRefExternal>.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2006-03-22" lims:fid="701138" lims:id="701138">SOR/2004-119, s. 1</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261688" lims:id="1261688" lims:enactId="1261136">SOR/2020-212, s. 3</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2023-11-24" lims:enacted-date="2023-11-24" lims:fid="1429318" lims:id="1429318" lims:enactId="1429003">SOR/2023-247, s. 10</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2023-02-15" lims:enacted-date="2023-02-03" lims:fid="1391086" lims:id="1391086" level="2"><TitleText>Public or Canadian Armed Forces Health Emergencies</TitleText></Heading><Section lims:inforce-start-date="2023-02-15" lims:enacted-date="2023-02-03" lims:lastAmendedDate="2023-02-15" lims:fid="1391087" lims:id="1391087"><Label>103.15</Label><Subsection lims:inforce-start-date="2023-02-15" lims:enacted-date="2023-02-03" lims:fid="1391088" lims:id="1391088"><Label>(1)</Label><Text>Sections C.11.002 and C.11.003 of the <XRefExternal reference-type="regulation" link="C.R.C.,_c._870">Food and Drug Regulations</XRefExternal> apply in respect of natural health products for which a product licence has not been issued.</Text></Subsection><Subsection lims:inforce-start-date="2023-02-15" lims:enacted-date="2023-02-03" lims:fid="1391089" lims:id="1391089"><Label>(2)</Label><Text>If the Minister issues an authorization to sell a specified quantity of a natural health product under subsection C.11.003(1) of the <XRefExternal reference-type="regulation" link="C.R.C.,_c._870">Food and Drug Regulations</XRefExternal>, any quantities of the drug that are sold in accordance with the authorization cease to be considered to be natural health products as of the time of sale.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2023-02-15" lims:enacted-date="2023-02-03" lims:fid="1391091" lims:id="1391091" lims:enactId="1390702">SOR/2023-18, s. 5</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="701139" lims:id="701139" level="2"><TitleText>Exemptions</TitleText></Heading><Heading lims:inforce-start-date="2018-04-04" lims:fid="701140" lims:id="701140" level="3"><TitleText>Advertising</TitleText></Heading><Section lims:inforce-start-date="2021-03-31" lims:enacted-date="2021-03-18" lims:lastAmendedDate="2021-03-31" lims:fid="701141" lims:id="1290022"><Label>103.2</Label><Text>A natural health product is exempt from subsection 3(1) of the Act with respect to its advertisement to the general public as a preventative, but not as a treatment or cure, for any of the diseases, disorders or abnormal physical states referred to in Schedule A.1 to the Act.</Text><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2008-06-01" lims:fid="701143" lims:id="701143">SOR/2007-288, s. 2</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2021-03-31" lims:enacted-date="2021-03-18" lims:fid="1290021" lims:id="1290021" lims:enactId="1288931">SOR/2021-46, s. 16</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="701144" lims:id="701144" level="3"><TitleText>Sale</TitleText></Heading><Section lims:inforce-start-date="2021-03-31" lims:enacted-date="2021-03-18" lims:lastAmendedDate="2021-03-31" lims:fid="701145" lims:id="1290024"><Label>103.3</Label><Text>A natural health product is exempt from subsection 3(2) of the Act with respect to its sale by a person where the natural health product is represented by label or is advertised by that person to the general public as a preventative, but not as a treatment or cure, for any of the diseases, disorders or abnormal physical states referred to in Schedule A.1 to the Act.</Text><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2008-06-01" lims:fid="701147" lims:id="701147">SOR/2007-288, s. 2</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2021-03-31" lims:enacted-date="2021-03-18" lims:fid="1290023" lims:id="1290023" lims:enactId="1288931">SOR/2021-46, s. 16</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2020-07-01" lims:enacted-date="2020-04-07" lims:fid="1254114" lims:id="1254114" level="2"><TitleText>Distribution of Natural Health Products as Samples</TitleText></Heading><Section lims:inforce-start-date="2020-07-01" lims:enacted-date="2020-04-07" lims:lastAmendedDate="2020-07-01" lims:fid="1254091" lims:id="1254091"><Label>103.4</Label><Subsection lims:inforce-start-date="2020-07-01" lims:enacted-date="2020-04-07" lims:fid="1254092" lims:id="1254092"><Label>(1)</Label><Text>If a practitioner or pharmacist has signed an order specifying the proper name or common name, the brand name and the quantity of a natural health product, the person who receives the order may distribute or cause to be distributed the natural health product, in dosage form, as a sample to that practitioner or pharmacist if the natural health product meets the requirements of these Regulations.</Text></Subsection><Subsection lims:inforce-start-date="2020-07-01" lims:enacted-date="2020-04-07" lims:fid="1254093" lims:id="1254093"><Label>(2)</Label><Text>An order referred to in subsection (1) may provide that the order be repeated at specified intervals during any period that does not exceed six months.</Text></Subsection><Subsection lims:inforce-start-date="2020-07-01" lims:enacted-date="2020-04-07" lims:fid="1254094" lims:id="1254094"><Label>(3)</Label><Text>Despite subsection (1), a person may distribute or cause to be distributed a natural health product, in dosage form, as a sample to a practitioner or pharmacist without a signed order if that natural health product has a localized effect and is for administration either in the oral cavity or on the skin, or is a throat lozenge, and if all of the following conditions are met:</Text><Paragraph lims:inforce-start-date="2020-07-01" lims:enacted-date="2020-04-07" lims:fid="1254095" lims:id="1254095"><Label>(a)</Label><Text>the natural health product is part of a class of natural health products that is set out in column 1 of List A and contains, as its only medicinal ingredients, one or more of those set out in column 2, each of which corresponds to that class, in the corresponding quantity set out in column 3, and the natural health product is consistent with the descriptive information set out in columns 4 to 6;</Text></Paragraph><Paragraph lims:inforce-start-date="2020-07-01" lims:enacted-date="2020-04-07" lims:fid="1254096" lims:id="1254096"><Label>(b)</Label><Text>the expiry date of the natural health product falls on a day that is</Text><Subparagraph lims:inforce-start-date="2020-07-01" lims:enacted-date="2020-04-07" lims:fid="1254097" lims:id="1254097"><Label>(i)</Label><Text>at least 30 days after the day on which it is distributed, if the expiry date consists of a day, month and year, or</Text></Subparagraph><Subparagraph lims:inforce-start-date="2020-07-01" lims:enacted-date="2020-04-07" lims:fid="1254098" lims:id="1254098"><Label>(ii)</Label><Text>in a month that follows the month in which it is distributed, if the expiry date consists only of a month and year;</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2020-07-01" lims:enacted-date="2020-04-07" lims:fid="1254099" lims:id="1254099"><Label>(c)</Label><Text>the natural health product meets the requirements of these Regulations.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2020-07-01" lims:enacted-date="2020-04-07" lims:fid="1254100" lims:id="1254100"><Label>(4)</Label><Text>For the purposes of this section, <DefinitionRef>practitioner</DefinitionRef> and <DefinitionRef>pharmacist</DefinitionRef> have the same meaning as in subsection C.01.001(1) of the <XRefExternal reference-type="regulation" link="C.R.C.,_c._870">Food and Drug Regulations</XRefExternal>.</Text></Subsection><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2020-07-01" lims:enacted-date="2020-04-07" lims:fid="1254102" lims:id="1254102" lims:enactId="1243927">SOR/2020-75, s. 2</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2020-07-01" lims:enacted-date="2020-04-07" lims:lastAmendedDate="2020-07-01" lims:fid="1254103" lims:id="1254103"><Label>103.5</Label><Text>A person who, under subsection 103.4(1), receives an order for and distributes or causes to be distributed a natural health product as a sample shall</Text><Paragraph lims:inforce-start-date="2020-07-01" lims:enacted-date="2020-04-07" lims:fid="1254104" lims:id="1254104"><Label>(a)</Label><Text>maintain records showing</Text><Subparagraph lims:inforce-start-date="2020-07-01" lims:enacted-date="2020-04-07" lims:fid="1254105" lims:id="1254105"><Label>(i)</Label><Text>the name, address and description of each person to whom the natural health product was distributed,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2020-07-01" lims:enacted-date="2020-04-07" lims:fid="1254106" lims:id="1254106"><Label>(ii)</Label><Text>the brand name, quantity and dosage form of the natural health product distributed, and</Text></Subparagraph><Subparagraph lims:inforce-start-date="2020-07-01" lims:enacted-date="2020-04-07" lims:fid="1254107" lims:id="1254107"><Label>(iii)</Label><Text>the date on which the natural health product was distributed; and</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2020-07-01" lims:enacted-date="2020-04-07" lims:fid="1254108" lims:id="1254108"><Label>(b)</Label><Text>keep those records and all orders received for natural health products under subsection 103.4(1) for a period of not less than two years from the date on which the distribution referred to in the records was made.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2020-07-01" lims:enacted-date="2020-04-07" lims:fid="1254110" lims:id="1254110" lims:enactId="1243927">SOR/2020-75, s. 2</HistoricalNoteSubItem></HistoricalNote></Section><Section lims:inforce-start-date="2020-07-01" lims:enacted-date="2020-04-07" lims:lastAmendedDate="2020-07-01" lims:fid="1254111" lims:id="1254111"><Label>103.6</Label><Text>A person may distribute or cause to be distributed a natural health product, in dosage form, as a sample to any consumer that is 18 years of age or older if that natural health product has a localized effect and is for administration either in the oral cavity or on the skin, or is a throat lozenge, and if all of the following conditions are met:</Text><Paragraph lims:inforce-start-date="2020-07-01" lims:enacted-date="2020-04-07" lims:fid="1316543" lims:id="1316543"><Label>(a)</Label><Text>the natural health product is part of a class of natural health products that is set out in column 1 of List A and contains, as its only medicinal ingredients, one or more of those set out in column 2, each of which corresponds to that class, in the corresponding quantity set out in column 3, and the natural health product is consistent with the descriptive information set out in columns 4 to 6;</Text></Paragraph><Paragraph lims:inforce-start-date="2020-07-01" lims:enacted-date="2020-04-07" lims:fid="1316544" lims:id="1316544"><Label>(b)</Label><Text>the expiry date of the natural health product falls on a day that is</Text><Subparagraph lims:inforce-start-date="2020-07-01" lims:enacted-date="2020-04-07" lims:fid="1316545" lims:id="1316545"><Label>(i)</Label><Text>at least 30 days after the day on which it is distributed, if the expiry date consists of a day, month and year,</Text></Subparagraph><Subparagraph lims:inforce-start-date="2020-07-01" lims:enacted-date="2020-04-07" lims:fid="1316546" lims:id="1316546"><Label>(ii)</Label><Text>in a month that follows the month in which it is distributed, if the expiry date consists only of a month and year;</Text></Subparagraph></Paragraph><Paragraph lims:inforce-start-date="2020-07-01" lims:enacted-date="2020-04-07" lims:fid="1316547" lims:id="1316547"><Label>(c)</Label><Text>the natural health product meets the requirements of these Regulations.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2020-07-01" lims:enacted-date="2020-04-07" lims:fid="1254113" lims:id="1254113" lims:enactId="1243927">SOR/2020-75, s. 2</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="701148" lims:id="701148" level="1"><Label>PART 6</Label><TitleText>Amendments, Transitional Provisions and Coming into Force</TitleText></Heading><Heading lims:inforce-start-date="2018-04-04" lims:fid="701149" lims:id="701149" level="2"><TitleText>Amendments</TitleText></Heading><Heading lims:inforce-start-date="2018-04-04" lims:fid="701150" lims:id="701150" level="3"><TitleText><XRefExternal reference-type="regulation" link="C.R.C.,_c._870">Food and Drug Regulations</XRefExternal></TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="701151" lims:id="701151"><Label>104</Label><Text>[Amendment]</Text></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="701152" lims:id="701152"><Label>105</Label><Text>[Amendment]</Text></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="701153" lims:id="701153"><Label>106</Label><Text>[Amendment]</Text></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="701154" lims:id="701154"><Label>107</Label><Text>[Amendment]</Text></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="701155" lims:id="701155" level="2"><TitleText>Transitional Provisions</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="701156" lims:id="701156" type="transitional"><Label>108</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="701157" lims:id="701157" type="transitional"><Label>(1)</Label><Text>Subject to section 110, a person may, without complying with these Regulations, sell a drug to which these Regulations apply that is assigned a drug identification number in accordance with section C.01.014.2(1) of the <XRefExternal reference-type="regulation" link="C.R.C.,_c._870">Food and Drug Regulations</XRefExternal>, until the earlier of</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="701158" lims:id="701158" type="transitional"><Label>(a)</Label><Text>the day on which an application for a product licence in respect of the drug is disposed of or withdrawn, and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="701159" lims:id="701159" type="transitional"><Label>(b)</Label><Text>December 31, 2009.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="701160" lims:id="701160" type="transitional"><Label>(2)</Label><Text>A person who sells a drug under subsection (1) shall conduct that sale in accordance with the requirements of the <XRefExternal reference-type="regulation" link="C.R.C.,_c._870">Food and Drug Regulations</XRefExternal>.</Text></Subsection></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="701161" lims:id="701161" type="transitional"><Label>109</Label><Text>An application for a product licence that is made in respect of a drug referred to in subsection 108(1) on or before December 31, 2009 is not required to contain the information referred to in paragraph 5(g).</Text></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="701162" lims:id="701162" type="transitional"><Label>110</Label><Text>A sale or importation of a drug to which these Regulations apply that, before January 1, 2004, is authorized for the purposes of a clinical trial under Division 5 of Part C of the <XRefExternal reference-type="regulation" link="C.R.C.,_c._870">Food and Drug Regulations</XRefExternal> shall continue to be regulated under that Division.</Text></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="701163" lims:id="701163" type="transitional"><Label>111</Label><Text>Until December 31, 2009, a person may sell a lot or batch of a drug referred to in section 108 that is not labelled or packaged in accordance with the requirements of Part 5 if the lot or batch is packaged in accordance with the requirements of the <XRefExternal reference-type="regulation" link="C.R.C.,_c._870">Food and Drug Regulations</XRefExternal>.</Text></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="701164" lims:id="701164" type="transitional"><Label>112</Label><Text>If during the period beginning on January 1, 2004 and ending on December 31, 2005, the information referred to in section 22 is not available to the licensee prior to commencing the sale of the natural health product or within 30 days after the day on which the license is issued in respect of the natural health product, as the case may be, the licensee shall provide the information to the Minister immediately after it is available to the licensee.</Text></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="701165" lims:id="701165" type="transitional"><Label>113</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="701166" lims:id="701166" type="transitional"><Label>(1)</Label><Text>A person who, before January 1, 2004, manufactures, packages, labels or imports for sale a drug to which these Regulations apply may continue to conduct the activity in respect of that drug without complying with the requirements of Parts 2 and 3, until the earlier of</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="701167" lims:id="701167" type="transitional"><Label>(a)</Label><Text>the day on which that person’s application for a site licence to conduct that activity in respect of the drug is disposed of or withdrawn, and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="701168" lims:id="701168" type="transitional"><Label>(b)</Label><Text>December 31, 2005.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="701169" lims:id="701169" type="transitional"><Label>(2)</Label><Text>A person who conducts an activity under subsection (1) shall conduct that activity in accordance with the requirements of the <XRefExternal reference-type="regulation" link="C.R.C.,_c._870">Food and Drug Regulations</XRefExternal>.</Text></Subsection></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="701170" lims:id="701170" type="transitional"><Label>114</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="701171" lims:id="701171" type="transitional"><Label>(1)</Label><Text>A person who, before January 1, 2004, distributes a drug to which these Regulations apply may continue to conduct the activity in respect of that drug without complying with the requirements of Part 3 until December 31, 2005.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="701172" lims:id="701172" type="transitional"><Label>(2)</Label><Text>A person who conducts an activity under subsection (1) shall conduct that activity in accordance with the requirements of Division 2 of Part C of the <XRefExternal reference-type="regulation" link="C.R.C.,_c._870">Food and Drug Regulations</XRefExternal>.</Text></Subsection></Section><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2021-03-31" lims:fid="701173" lims:id="701173" type="transitional"><Label>115</Label><Text>A person may sell a lot or batch of a drug referred to in section 108 that is not manufactured, packaged, labelled, imported, distributed or stored, as the case may be, in accordance with the requirements of Part 3 if</Text><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="701174" lims:id="701174" type="transitional"><Label>(a)</Label><Text>the lot or batch is manufactured, packaged and labelled before January 1, 2006; and</Text></Paragraph><Paragraph lims:inforce-start-date="2006-03-22" lims:fid="701175" lims:id="701175" type="transitional"><Label>(b)</Label><Text>any manufacturing, packaging, labelling, importation, distribution or storage of the lot or batch that is not conducted in accordance with the requirements of Part 3 is conducted in accordance with the requirements of Division 2 of Part C of the <XRefExternal reference-type="regulation" link="C.R.C.,_c._870">Food and Drug Regulations</XRefExternal>.</Text></Paragraph><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2021-03-31" lims:enacted-date="2021-03-18" lims:fid="1290048" lims:id="1290048" lims:enactId="1288932">SOR/2021-46, s. 17(F)</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2021-03-31" lims:enacted-date="2021-03-18" lims:fid="1290049" lims:id="1290049" lims:enactId="1288951">SOR/2021-46, s. 18(F)</HistoricalNoteSubItem></HistoricalNote></Section><Heading lims:inforce-start-date="2018-04-04" lims:fid="701176" lims:id="701176" level="2"><TitleText>Coming into Force</TitleText></Heading><Section lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="701177" lims:id="701177" type="transitional"><Label>116</Label><Subsection lims:inforce-start-date="2006-03-22" lims:fid="701178" lims:id="701178" type="transitional"><Label>(1)</Label><Text>Except for section 6, these Regulations come into force on January 1, 2004.</Text></Subsection><Subsection lims:inforce-start-date="2006-03-22" lims:fid="701179" lims:id="701179" type="transitional"><Label>(2)</Label><Text>Section 6 comes into force on July 1, 2004.</Text></Subsection></Section></Body><Schedule lims:inforce-start-date="2006-03-22" lims:lastAmendedDate="2006-03-22" lims:fid="701180" lims:id="701180" spanlanguages="no" bilingual="no"><ScheduleFormHeading lims:inforce-start-date="2006-03-22" lims:fid="701181" lims:id="701181"><Label>SCHEDULE 1</Label><OriginatingRef>(Subsection 1(1))</OriginatingRef></ScheduleFormHeading><TableGroup lims:inforce-start-date="2006-03-22" lims:fid="701182" lims:id="701182" bilingual="no" pointsize="8" rowbreak="no" spanlanguages="no" topmarginspacing="4"><table lims:inforce-start-date="2006-03-22" lims:fid="701184" lims:id="701184" frame="topbot"><title lims:inforce-start-date="2006-03-22" lims:fid="1261769" lims:id="1261769">Included Natural Health Product Substances</title><tgroup lims:inforce-start-date="2006-03-22" lims:fid="701185" lims:id="701185" cols="2"><colspec colname="1" colwidth="0.75*" /><colspec colname="2" colwidth="5.25*" /><thead lims:inforce-start-date="2006-03-22" lims:fid="701186" lims:id="701186"><row topdouble="yes"><entry colname="1" colsep="0" rowsep="1" valign="bottom">Item</entry><entry colname="2" colsep="0" rowsep="1" valign="bottom">Substances</entry></row></thead><tbody lims:inforce-start-date="2006-03-22" lims:fid="701187" lims:id="701187"><row valign="bottom"><entry colname="1" colsep="0" rowsep="0" valign="top">1</entry><entry colname="2" colsep="0" rowsep="0">A plant or a plant material, an alga, a bacterium, a fungus or a non-human animal material</entry></row><row><entry colname="1" colsep="0" rowsep="0" valign="top">2</entry><entry colname="2" colsep="0" rowsep="0" valign="top">An extract or isolate of a substance described in item 1, the primary molecular structure of which is identical to that which it had prior to its extraction or isolation</entry></row><row><entry colname="1" colsep="0" rowsep="0" valign="top">3</entry><entry colname="2" colsep="0" rowsep="0" valign="top"><Provision format-ref="indent-0-0"><Text>Any of the following vitamins:</Text><List first-line-indent="0" subsequent-line-indent="0"><Item><Text>biotin</Text></Item><Item><Text>folate</Text></Item><Item><Text>niacin</Text></Item><Item><Text>pantothenic acid</Text></Item><Item><Text>riboflavin</Text></Item><Item><Text>thiamine</Text></Item><Item><Text>vitamin A</Text></Item><Item><Text>vitamin B<Sub>6</Sub></Text></Item><Item><Text>vitamin B<Sub>12</Sub></Text></Item><Item><Text>vitamin C</Text></Item><Item><Text>vitamin D</Text></Item><Item><Text>vitamin E</Text></Item><Item><Text>vitamin K<Sub>1</Sub></Text></Item><Item><Text>vitamin K<Sub>2</Sub></Text></Item></List></Provision></entry></row><row><entry colname="1" colsep="0" rowsep="0" valign="top">4</entry><entry colname="2" colsep="0" rowsep="0" valign="top">An amino acid</entry></row><row><entry colname="1" colsep="0" rowsep="0" valign="top">5</entry><entry colname="2" colsep="0" rowsep="0" valign="top">An essential fatty acid</entry></row><row><entry colname="1" colsep="0" rowsep="0" valign="top">6</entry><entry colname="2" colsep="0" rowsep="0" valign="top">A synthetic duplicate of a substance described in any of items 2 to 5</entry></row><row><entry colname="1" colsep="0" rowsep="0" valign="top">7</entry><entry colname="2" colsep="0" rowsep="0" valign="top">A mineral</entry></row><row><entry colname="1" colsep="0" rowsep="0" valign="top">8</entry><entry colname="2" colsep="0" rowsep="0" valign="top">A probiotic</entry></row></tbody></tgroup></table></TableGroup><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2006-03-22" lims:fid="701189" lims:id="701189">SOR/2005-308, s. 1</HistoricalNoteSubItem></HistoricalNote></Schedule><Schedule lims:inforce-start-date="2018-10-17" lims:lastAmendedDate="2025-05-31" lims:fid="701190" lims:id="701190" spanlanguages="no" bilingual="no"><ScheduleFormHeading lims:inforce-start-date="2018-10-17" lims:fid="701191" lims:id="701191"><Label>SCHEDULE 2</Label><OriginatingRef>(Subsection 1(1))</OriginatingRef></ScheduleFormHeading><TableGroup lims:inforce-start-date="2018-10-17" lims:fid="701192" lims:id="701192" pointsize="8" topmarginspacing="10" rowbreak="no" bilingual="no" spanlanguages="no"><table lims:inforce-start-date="2018-10-17" lims:fid="701193" lims:id="701193" frame="topbot"><title lims:inforce-start-date="2018-10-17" lims:fid="701194" lims:id="701194">Excluded Natural Health Product Substances</title><tgroup lims:inforce-start-date="2018-10-17" lims:fid="701195" lims:id="701195" cols="2"><colspec colname="1" colwidth="0.84*" /><colspec colname="COLSPEC0" colwidth="6.75*" /><thead lims:inforce-start-date="2018-10-17" lims:fid="701196" lims:id="701196"><row topdouble="yes"><entry colname="1" colsep="0" rowsep="1" valign="bottom">Item</entry><entry colsep="0" rowsep="1" valign="bottom">Substances</entry></row></thead><tbody lims:inforce-start-date="2018-10-17" lims:fid="701197" lims:id="701197"><row valign="bottom"><entry colname="1" colsep="0" rowsep="0" valign="top">1</entry><entry colsep="0" rowsep="0" valign="top">A substance set out in Schedule C to the Act</entry></row><row><entry colname="1" colsep="0" rowsep="0" valign="top">2</entry><entry colsep="0" rowsep="0"><Provision format-ref="indent-0-0"><Text>A substance set out in Schedule D to the Act, except for the following:</Text><Provision format-ref="indent-1-1"><Label>(a)</Label><Text>a drug that is prepared from any of the following micro-organisms, namely, an alga, a bacterium or a fungus; and</Text></Provision><Provision format-ref="indent-1-1"><Label>(b)</Label><Text>any substance set out on Schedule D when it is prepared in accordance with the practices of homeopathic pharmacy</Text></Provision></Provision></entry></row><row><entry colname="1" colsep="0" rowsep="0" valign="top">3</entry><entry colsep="0" rowsep="0"><Repealed>[Repealed, SOR/2018-132, s. 3]</Repealed></entry></row><row><entry colname="1" colsep="0" rowsep="0" valign="top">4</entry><entry colsep="0" rowsep="0">A substance set out in any of Schedules I to V of the <XRefExternal reference-type="act" link="C-38.8">Controlled Drugs and Substances Act</XRefExternal></entry></row><row><entry colname="1" colsep="0" rowsep="0" valign="top">5</entry><entry colsep="0" rowsep="0">A substance that is administered by puncturing the dermis</entry></row><row><entry colname="1" colsep="0" rowsep="0" valign="top">6</entry><entry colsep="0" rowsep="0">An antibiotic prepared from an alga, a bacterium or a fungus or a synthetic duplicate of that antibiotic</entry></row><row lims:inforce-start-date="2025-03-12" lims:enacted-date="2025-02-26" lims:fid="1515759" lims:id="1523374"><entry colsep="0" rowsep="0">7</entry><entry colsep="0" rowsep="0"><Provision format-ref="indent-0-0"><Text><DefinitionRef>Cannabis</DefinitionRef> as defined in subsection 2(1) of the <XRefExternal reference-type="act" link="C-24.5">Cannabis Act</XRefExternal></Text></Provision></entry></row><row lims:inforce-start-date="2018-10-17" lims:fid="1457208" lims:id="1457208"><entry colsep="0" rowsep="0">8</entry><entry colsep="0" rowsep="0">Anything referred to in Schedule 2 to the <XRefExternal reference-type="act" link="C-24.5">Cannabis Act</XRefExternal> that contains more than 10 μg/g THC, an isolated or concentrated phytocannabinoid or a synthetic duplicate of that phytocannabinoid</entry></row><row lims:inforce-start-date="2025-05-31" lims:enacted-date="2024-05-31" lims:fid="1531297" lims:id="1531297"><entry colsep="0" rowsep="0">9</entry><entry colsep="0" rowsep="0">A drug that is manufactured, sold or represented for use in destroying or inactivating micro-organisms, or in reducing or controlling their number, on a non-living and non-liquid surface</entry></row></tbody></tgroup></table></TableGroup><HistoricalNote><HistoricalNoteSubItem lims:inforce-start-date="2018-10-17" lims:fid="701199" lims:id="701199">2018, c. 9, s. 77; SOR/2018-132, s. 3; SOR/2018-144, s. 372</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2025-05-31" lims:enacted-date="2024-05-31" lims:fid="1531299" lims:id="1531299" lims:enactId="1457118">SOR/2024-110, s. 84</HistoricalNoteSubItem><HistoricalNoteSubItem lims:inforce-start-date="2025-03-12" lims:enacted-date="2025-02-26" lims:fid="1523375" lims:id="1523375" lims:enactId="1515027">SOR/2025-43, s. 74</HistoricalNoteSubItem></HistoricalNote></Schedule><Schedule id="RelatedProvs"><ScheduleFormHeading type="amending"><TitleText>RELATED PROVISIONS</TitleText></ScheduleFormHeading><RegulationPiece><RelatedOrNotInForce><Heading level="5" style="nifrp"><TitleText>
                    — SOR/2022-146, s. 24</TitleText></Heading><Section><Label>24</Label><Subsection><Label>(1)</Label><Text>The following definitions apply in this section.</Text><Definition><Text><DefinedTermEn>former Regulations</DefinedTermEn> means the <XRefExternal reference-type="regulation" link="SOR-2003-196">Natural Health Products Regulations</XRefExternal> as they read immediately before the day on which sections 17 to 22 of these Regulations come into force. (<DefinedTermFr>ancien règlement</DefinedTermFr>)</Text></Definition><Definition><Text><DefinedTermEn>natural health product</DefinedTermEn> has the same meaning as in subsection 1(1) of the <XRefExternal reference-type="regulation" link="SOR-2003-196">Natural Health Products Regulations</XRefExternal>. (<DefinedTermFr>produit de santé naturel</DefinedTermFr>)</Text></Definition><Definition><Text><DefinedTermEn>new Regulations</DefinedTermEn> means the <XRefExternal reference-type="regulation" link="SOR-2003-196">Natural Health Products Regulations</XRefExternal> as they read on the day on which sections 17 to 22 of these Regulations come into force. (<DefinedTermFr>nouveau règlement</DefinedTermFr>)</Text></Definition></Subsection><Subsection><Label>(2)</Label><Text>A natural health product for which a product licence has been issued under section 7 of the former Regulations is not required, within three years after the day on which sections 17 to 22 of these Regulations come into force, to be labelled in accordance with the new Regulations, if the product is labelled in accordance with the former Regulations.</Text></Subsection><Subsection><Label>(3)</Label><Text>If, during the three-year period referred to in subsection (2), a person that holds a product licence under the former Regulations in respect of a natural health product referred to in that subsection makes any modification of risk information referred to in paragraph 11(1)(c) of the former Regulations in respect of the product for the purpose of complying with the new Regulations,</Text><Paragraph><Label>(a)</Label><Text>section 11 of the former Regulations does not apply in respect of the modification of risk information; and</Text></Paragraph><Paragraph><Label>(b)</Label><Text>the modification is to be considered as a change to which section 12 of the former Regulations applies.</Text></Paragraph></Subsection></Section></RelatedOrNotInForce></RegulationPiece></Schedule><RecentAmendments><Amendment><AmendmentCitation>SOR/2022-146</AmendmentCitation><AmendmentDate>2025-06-21</AmendmentDate></Amendment><Amendment><AmendmentCitation>SOR/2024-110</AmendmentCitation><AmendmentDate>2025-05-31</AmendmentDate></Amendment><Amendment><AmendmentCitation>SOR/2025-43</AmendmentCitation><AmendmentDate>2025-03-12</AmendmentDate></Amendment><Amendment><AmendmentCitation>SOR/2023-247</AmendmentCitation><AmendmentDate>2023-11-24</AmendmentDate></Amendment><Amendment><AmendmentCitation>SOR/2023-18</AmendmentCitation><AmendmentDate>2023-02-15</AmendmentDate></Amendment><Amendment><AmendmentCitation>SOR/2022-146</AmendmentCitation><AmendmentDate>2022-06-21</AmendmentDate></Amendment><Amendment><AmendmentCitation>SOR/2022-18</AmendmentCitation><AmendmentDate>2022-02-11</AmendmentDate></Amendment><Amendment><AmendmentCitation>SOR/2021-46</AmendmentCitation><AmendmentDate>2021-03-31</AmendmentDate></Amendment><Amendment><AmendmentCitation>SOR/2020-212</AmendmentCitation><AmendmentDate>2020-09-28</AmendmentDate></Amendment><Amendment><AmendmentCitation>SOR/2020-75</AmendmentCitation><AmendmentDate>2020-07-01</AmendmentDate></Amendment></RecentAmendments></Regulation>